Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy

Fabrication and in vitro characterization of... | F1000Research "use strict";function _typeof(t){return(_typeof="function"==typeof Symbol&&"symbol"==typeof Symbol.iterator?function(t){return typeof t}:function(t){return t&&"function"==typeof Symbol&&t.constructor===Symbol&&t!==Symbol.prototype?"symbol":typeof t})(t)}!function(){var t=function(){var t,e,o=[],n=window,r=n;for(;r;){try{if(r.frames.__tcfapiLocator){t=r;break}}catch(t){}if(r===n.top)break;r=r.parent}t||(!function t(){var e=n.document,o=!!n.frames.__tcfapiLocator;if(!o)if(e.body){var r=e.createElement("iframe");r.style.cssText="display:none",r.name="__tcfapiLocator",e.body.appendChild(r)}else setTimeout(t,5);return!o}(),n.__tcfapi=function(){for(var t=arguments.length,n=new Array(t),r=0;r 3&&2===parseInt(n[1],10)&&"boolean"==typeof n[3]&&(e=n[3],"function"==typeof n[2]&&n[2]("set",!0)):"ping"===n[0]?"function"==typeof n[2]&&n[2]({gdprApplies:e,cmpLoaded:!1,cmpStatus:"stub"}):o.push(n)},n.addEventListener("message",(function(t){var e="string"==typeof t.data,o={};if(e)try{o=JSON.parse(t.data)}catch(t){}else o=t.data;var n="object"===_typeof(o)&&null!==o?o.__tcfapiCall:null;n&&window.__tcfapi(n.command,n.version,(function(o,r){var a={__tcfapiReturn:{returnValue:o,success:r,callId:n.callId}};t&&t.source&&t.source.postMessage&&t.source.postMessage(e?JSON.stringify(a):a,"*")}),n.parameter)}),!1))};"undefined"!=typeof module?module.exports=t:t()}(); dataLayer = dataLayer || []; // Standard GTM initialization - Google Consent Mode handles consent automatically (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+ '>m_auth=hzk0Vc3qFsQYhCrIoHz68A>m_preview=env-1>m_cookies_win=x';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-MWFK8L5J'); ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]}}; ;NREUM.loader_config={accountID:"438030",trustKey:"438030",agentID:"772317073",licenseKey:"97f8f67f26",applicationID:"772317073"} ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"97f8f67f26",applicationID:"772317073",sa:1} ;/*! For license information please see nr-loader-spa-1.236.0.min.js.LICENSE.txt */ (()=>{"use strict";var e,t,r={5763:(e,t,r)=>{r.d(t,{P_:()=>l,Mt:()=>g,C5:()=>s,DL:()=>v,OP:()=>T,lF:()=>D,Yu:()=>y,Dg:()=>h,CX:()=>c,GE:()=>b,sU:()=>_});var n=r(8632),i=r(9567);const o={beacon:n.ce.beacon,errorBeacon:n.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function c(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.D)(t,o),(0,n.Qy)(e,a[e],"info")}var u=r(7056);const d=()=>{const e={blockSelector:"[data-nr-block]",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:u.oD,inactiveMs:u.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:"*",maskAllInputs:!0,get blockClass(){return"nr-block"},get ignoreClass(){return"nr-ignore"},get maskTextClass(){return"nr-mask"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=",".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},f={};function l(e){if(!e)throw new Error("All configuration objects require an agent identifier!");if(!f[e])throw new Error("Configuration for ".concat(e," was never set"));return f[e]}function h(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");f[e]=(0,i.D)(t,d()),(0,n.Qy)(e,f[e],"config")}function g(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");var r=l(e);if(r){for(var n=t.split("."),i=0;i {r.d(t,{D:()=>i});var n=r(50);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.Z)("Setting a Configurable requires an object as input");if(!t||"object"!=typeof t)return(0,n.Z)("Setting a Configurable requires a model to set its initial properties");const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.Z)("An error occurred while setting a property of a Configurable",e)}return r}catch(e){(0,n.Z)("An error occured while setting a Configurable",e)}}},6818:(e,t,r)=>{r.d(t,{Re:()=>i,gF:()=>o,q4:()=>n});const n="1.236.0",i="PROD",o="CDN"},385:(e,t,r)=>{r.d(t,{FN:()=>a,IF:()=>u,Nk:()=>f,Tt:()=>s,_A:()=>o,il:()=>n,pL:()=>c,v6:()=>i,w1:()=>d});const n="undefined"!=typeof window&&!!window.document,i="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=n?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=""+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&"undefined"==typeof SharedWorker,u=(()=>{const e=navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),d=Boolean(n&&window.document.documentMode),f=!!navigator.sendBeacon},1117:(e,t,r)=>{r.d(t,{w:()=>o});var n=r(50);const i={agentIdentifier:"",ee:void 0};class o{constructor(e){try{if("object"!=typeof e)return(0,n.Z)("shared context requires an object as input");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,r]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=r)}))}catch(e){(0,n.Z)("An error occured while setting SharedContext",e)}}}},8e3:(e,t,r)=>{r.d(t,{L:()=>d,R:()=>c});var n=r(2177),i=r(1284),o=r(4322),a=r(3325);const s={};function c(e,t){const r={staged:!1,priority:a.p[t]||0};u(e),s[e].get(t)||s[e].set(t,r)}function u(e){e&&(s[e]||(s[e]=new Map))}function d(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:"",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:"feature";if(u(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const r=[...s[e]];function a(t){const r=e?n.ee.get(e):n.ee,a=o.X.handlers;if(r.backlog&&a){var s=r.backlog[t],c=a[t];if(c){for(var u=0;s&&u {let[t,r]=e;return r.staged}))&&(r.sort(((e,t)=>e[1].priority-t[1].priority)),r.forEach((e=>{let[t]=e;a(t)})))}function f(e,t){var r=e[1];(0,i.D)(t[r],(function(t,r){var n=e[0];if(r[0]===n){var i=r[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,r)=>{r.d(t,{c:()=>f,ee:()=>u});var n=r(8632),i=r(2210),o=r(1284),a=r(5763),s="nr@context";let c=(0,n.fP)();var u;function d(){}function f(e){return(0,i.X)(e,s,l)}function l(){return new d}function h(){u.aborted=!0,u.backlog={}}c.ee?u=c.ee:(u=function e(t,r){var n={},c={},f={},g=!1;try{g=16===r.length&&(0,a.OP)(r).isolatedBacklog}catch(e){}var p={on:b,addEventListener:b,removeEventListener:y,emit:v,get:x,listeners:w,context:m,buffer:A,abort:h,aborted:!1,isBuffering:E,debugId:r,backlog:g?{}:t&&"object"==typeof t.backlog?t.backlog:{}};return p;function m(e){return e&&e instanceof d?e:e?(0,i.X)(e,s,l):l()}function v(e,r,n,i,o){if(!1!==o&&(o=!0),!u.aborted||i){t&&o&&t.emit(e,r,n);for(var a=m(n),s=w(e),d=s.length,f=0;fn,p:()=>i});var n=r(2177).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},4322:(e,t,r)=>{r.d(t,{X:()=>o});var n=r(5546);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.E,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.E);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3239:(e,t,r)=>{r.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var n=r(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};n._A.addEventListener("test",null,e),n._A.removeEventListener("test",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(r,n))}function c(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(r,n))}},4402:(e,t,r)=>{r.d(t,{Ht:()=>u,M:()=>c,Rl:()=>a,ky:()=>s});var n=r(385);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n._A?.crypto||n._A?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split("").map((e=>"x"===e?o(t,++r).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n._A?.crypto||n._A?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s {r.d(t,{Bq:()=>n,Hb:()=>o,oD:()=>i});const n="NRBA",i=144e5,o=18e5},7894:(e,t,r)=>{function n(){return Math.round(performance.now())}r.d(t,{z:()=>n})},7243:(e,t,r)=>{r.d(t,{e:()=>o});var n=r(385),i={};function o(e){if(e in i)return i[e];if(0===(e||"").indexOf("data:"))return{protocol:"data"};let t;var r=n._A?.location,o={};if(n.il)t=document.createElement("a"),t.href=e;else try{t=new URL(e,r.href)}catch(e){return o}o.port=t.port;var a=t.href.split("://");!o.port&&a[1]&&(o.port=a[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===a[0]?"443":"80"),o.hostname=t.hostname||r.hostname,o.pathname=t.pathname,o.protocol=a[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var s=!t.protocol||":"===t.protocol||t.protocol===r.protocol,c=t.hostname===r.hostname&&t.port===r.port;return o.sameOrigin=s&&(!t.hostname||c),"/"===o.pathname&&(i[e]=o),o}},50:(e,t,r)=>{function n(e,t){"function"==typeof console.warn&&(console.warn("New Relic: ".concat(e)),t&&console.warn(t))}r.d(t,{Z:()=>n})},2587:(e,t,r)=>{r.d(t,{N:()=>c,T:()=>u});var n=r(2177),i=r(5546),o=r(8e3),a=r(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const r=n.ee.get(t);e&&"object"==typeof e&&(Object.entries(e).forEach((e=>{let[t,n]=e;void 0===u[t]&&(s[t]?s[t].forEach((e=>{n?(0,i.p)("feat-"+t,[],void 0,e,r):(0,i.p)("block-"+t,[],void 0,e,r),(0,i.p)("rumresp-"+t,[Boolean(n)],void 0,e,r)})):n&&(0,i.p)("feat-"+t,[],void 0,void 0,r),u[t]=Boolean(n))})),Object.keys(s).forEach((e=>{void 0===u[e]&&(s[e]?.forEach((t=>(0,i.p)("rumresp-"+e,[!1],void 0,t,r))),u[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const u={}},2210:(e,t,r)=>{r.d(t,{X:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,r)=>{r.d(t,{D:()=>n});const n=(e,t)=>Object.entries(e||{}).map((e=>{let[r,n]=e;return t(r,n)}))},4351:(e,t,r)=>{r.d(t,{P:()=>o});var n=r(2177);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}}}},3960:(e,t,r)=>{r.d(t,{K:()=>a,b:()=>o});var n=r(3239);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.bP)("load",e,t)}function a(e){if(i())return e();(0,n.iz)("DOMContentLoaded",e)}},8632:(e,t,r)=>{r.d(t,{EZ:()=>u,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>d,mF:()=>s});var n=r(7894),i=r(385);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,r){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,n.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[r]:t}},i}function u(e,t){a()[e]=t}function d(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,r)=>{r.d(t,{N:()=>i});var n=r(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],r=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,n.iz)("visibilitychange",(function(){if(t)return void("hidden"==document.visibilityState&&e());e(document.visibilityState)}),r,i)}},1214:(e,t,r)=>{r.d(t,{em:()=>v,u5:()=>N,QU:()=>S,_L:()=>I,Gm:()=>L,Lg:()=>M,gy:()=>U,BV:()=>Q,Kf:()=>ee});var n=r(2177);const i="nr@original";var o=Object.prototype.hasOwnProperty,a=!1;function s(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");var a,s,c,u="-"===n.charAt(0);for(c=0;c 2?n-2:0),o=2;o {r(A[T],e,w),r(E[T],e,w)})),r(l._A,"fetch",y),t.on(y+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(y+"done",[null,r],n)}else t.emit(y+"done",[e],n)})),t}const O={},j=["pushState","replaceState"];function S(e){const t=function(e){return(e||n.ee).get("history")}(e);return!l.il||O[t.debugId]++||(O[t.debugId]=1,s(t).inPlace(window.history,j,"-")),t}var P=r(3239);const C={},R=["appendChild","insertBefore","replaceChild"];function I(e){const t=function(e){return(e||n.ee).get("jsonp")}(e);if(!l.il||C[t.debugId])return t;C[t.debugId]=!0;var r=s(t),i=/[?&](?:callback|cb)=([^&#]+)/,o=/(.*)\.([^.]+)/,a=/^(\w+)(\.|$)(.*)$/;function c(e,t){var r=e.match(a),n=r[1],i=r[3];return i?c(i,t[n]):t[n]}return r.inPlace(Node.prototype,R,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var n=(a=e.src,s=a.match(i),s?s[1]:null);var a,s;if(!n)return;var u=function(e){var t=e.match(o);if(t&&t.length>=3)return{key:t[2],parent:c(t[1],window)};return{key:e,parent:window}}(n);if("function"!=typeof u.parent[u.key])return;var d={};function f(){t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}function l(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",f,(0,P.m$)(!1)),e.addEventListener("error",l,(0,P.m$)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}var k=r(5763);const H={};function L(e){const t=function(e){return(e||n.ee).get("mutation")}(e);if(!l.il||H[t.debugId])return t;H[t.debugId]=!0;var r=s(t),i=k.Yu.MO;return i&&(window.MutationObserver=function(e){return this instanceof i?new i(r(e,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype),t}const z={};function M(e){const t=function(e){return(e||n.ee).get("promise")}(e);if(z[t.debugId])return t;z[t.debugId]=!0;var r=n.c,o=s(t),a=k.Yu.PR;return a&&function(){function e(r){var n=t.context(),i=o(r,"executor-",n,null,!1);const s=Reflect.construct(a,[i],e);return t.context(s).getCtx=function(){return n},s}l._A.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return a.toString()},Object.setPrototypeOf(e,a),["all","race"].forEach((function(r){const n=a[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=a[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=a.prototype;const n=a.prototype.then;a.prototype.then=function(){var e=this,i=r(e);i.promise=e;for(var a=arguments.length,s=new Array(a),c=0;c e())),t};function m(e,t){i.inPlace(t,["onreadystatechange"],"fn-",E)}function b(){var e=this,t=r.context(e);e.readyState>3&&!t.resolved&&(t.resolved=!0,r.emit("xhr-resolved",[],e)),i.inPlace(e,f,"fn-",E)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,p),p.prototype=o.prototype,i.inPlace(p.prototype,J,"-xhr-",E),r.on("send-xhr-start",(function(e,t){m(e,t),function(e){h.push(e),a&&(y?y.then(A):u?u(A):(w=-w,x.data=w))}(t)})),r.on("open-xhr-start",m),a){var y=c&&c.resolve();if(!u&&!c){var w=1,x=document.createTextNode(w);new a(A).observe(x,{characterData:!0})}}else t.on("fn-end",(function(e){e[0]&&e[0].type===d||A()}));function A(){for(var e=0;e {r.d(t,{t:()=>n});const n=r(3325).D.ajax},6660:(e,t,r)=>{r.d(t,{A:()=>i,t:()=>n});const n=r(3325).D.jserrors,i="nr@seenError"},3081:(e,t,r)=>{r.d(t,{gF:()=>o,mY:()=>i,t9:()=>n,vz:()=>s,xS:()=>a});const n=r(3325).D.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},4649:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageAction},7633:(e,t,r)=>{r.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>n});const n=r(3325).D.pageViewEvent,i="firstbyte",o="domcontent",a="windowload"},9251:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageViewTiming},3614:(e,t,r)=>{r.d(t,{BST_RESOURCE:()=>i,END:()=>s,FEATURE_NAME:()=>n,FN_END:()=>u,FN_START:()=>c,PUSH_STATE:()=>d,RESOURCE:()=>o,START:()=>a});const n=r(3325).D.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState"},7836:(e,t,r)=>{r.d(t,{BODY:()=>A,CB_END:()=>E,CB_START:()=>u,END:()=>x,FEATURE_NAME:()=>i,FETCH:()=>_,FETCH_BODY:()=>v,FETCH_DONE:()=>m,FETCH_START:()=>p,FN_END:()=>c,FN_START:()=>s,INTERACTION:()=>l,INTERACTION_API:()=>d,INTERACTION_EVENTS:()=>o,JSONP_END:()=>b,JSONP_NODE:()=>g,JS_TIME:()=>T,MAX_TIMER_BUDGET:()=>a,REMAINING:()=>f,SPA_NODE:()=>h,START:()=>w,originalSetTimeout:()=>y});var n=r(5763);const i=r(3325).D.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",f="remaining",l="interaction",h="spaNode",g="jsonpNode",p="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=n.Yu.ST,w="-start",x="-end",A="-body",E="cb"+x,T="jsTime",_="fetch"},5938:(e,t,r)=>{r.d(t,{W:()=>o});var n=r(5763),i=r(2177);class o{constructor(e,t,r){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,n.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=r,this.blocked=!1}}},9144:(e,t,r)=>{r.d(t,{j:()=>m});var n=r(3325),i=r(5763),o=r(5546),a=r(2177),s=r(7894),c=r(8e3),u=r(3960),d=r(385),f=r(50),l=r(3081),h=r(8632);function g(){const e=(0,h.gG)();["setErrorHandler","finished","addToTrace","inlineHit","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId"].forEach((t=>{e[t]=function(){for(var r=arguments.length,n=new Array(r),i=0;i 1?r-1:0),i=1;i {e.exposed&&e.api[t]&&o.push(e.api[t](...n))})),o.length>1?o:o[0]}(t,...n)}}))}var p=r(2587);function m(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},m=arguments.length>2?arguments[2]:void 0,v=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:x={loaderType:m},exposed:A=!0}=t;const E=(0,h.gG)();y||(b=E.init,y=E.info,w=E.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,x),y.jsAttributes??={},d.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),g();const T=function(e,t){t||(0,c.R)(e,"api");const h={};var g=a.ee.get(e),p=g.get("tracer"),m="api-",v=m+"ixn-";function b(t,r,n,o){const a=(0,i.C5)(e);return null===r?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),x(m,n,!0,o||null===r?"session":void 0)(t,r)}function y(){}["setErrorHandler","finished","addToTrace","inlineHit","addRelease"].forEach((e=>h[e]=x(m,e,!0,"api"))),h.addPageAction=x(m,"addPageAction",!0,n.D.pageAction),h.setCurrentRouteName=x(m,"routeName",!0,n.D.spa),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,i.OP)(e).customTransaction=(r||"http://custom.transaction")+t,x(m,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if("string"==typeof e){if(["string","number"].includes(typeof t)||null===t)return b(e,t,"setCustomAttribute",r);(0,f.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of was provided."))}else(0,f.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of was provided."))},h.setUserId=function(e){if("string"==typeof e||null===e)return b("enduser.id",e,"setUserId",!0);(0,f.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of was provided."))},h.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var r={},i=this,a="function"==typeof t;return(0,o.p)(v+"tracer",[(0,s.z)(),e,r],i,n.D.spa,g),function(){if(p.emit((a?"":"no-")+"fn-start",[(0,s.z)(),i,a],r),a)try{return t.apply(this,arguments)}catch(e){throw p.emit("fn-err",[arguments,this,"string"==typeof e?new Error(e):e],r),e}finally{p.emit("fn-end",[(0,s.z)()],r)}}}};function x(e,t,r,i){return function(){return(0,o.p)(l.xS,["API/"+t+"/called"],void 0,n.D.metrics,g),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],r?null:this,i,g),r?void 0:this}}function A(){r.e(439).then(r.bind(r,7438)).then((t=>{let{setAPI:r}=t;r(e),(0,c.L)(e,"api")})).catch((()=>(0,f.Z)("Downloading runtime APIs failed...")))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{w[e]=x(v,e,void 0,n.D.spa)})),h.noticeError=function(e,t){"string"==typeof e&&(e=new Error(e)),(0,o.p)(l.xS,["API/noticeError/called"],void 0,n.D.metrics,g),(0,o.p)("err",[e,(0,s.z)(),!1,t],void 0,n.D.jserrors,g)},d.il?(0,u.b)((()=>A()),!0):A(),h}(e,v);return(0,h.Qy)(e,T,"api"),(0,h.Qy)(e,A,"exposed"),(0,h.EZ)("activatedFeatures",p.T),T}},3325:(e,t,r)=>{r.d(t,{D:()=>n,p:()=>i});const n={ajax:"ajax",jserrors:"jserrors",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.ajax]:5,[n.sessionTrace]:6,[n.pageAction]:7,[n.spa]:8,[n.sessionReplay]:9}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>(({78:"page_action-aggregate",147:"metrics-aggregate",242:"session-manager",317:"jserrors-aggregate",348:"page_view_timing-aggregate",412:"lazy-feature-loader",439:"async-api",538:"recorder",590:"session_replay-aggregate",675:"compressor",733:"session_trace-aggregate",786:"page_view_event-aggregate",873:"spa-aggregate",898:"ajax-aggregate"}[e]||e)+"."+{78:"ac76d497",147:"3dc53903",148:"1a20d5fe",242:"2a64278a",317:"49e41428",348:"bd6de33a",412:"2f55ce66",439:"30bd804e",538:"1b18459f",590:"cf0efb30",675:"ae9f91a8",733:"83105561",786:"06482edd",860:"03a8b7a5",873:"e6b09d52",898:"998ef92b"}[e]+"-1.236.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d {s.onerror=s.onload=null,clearTimeout(h);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},h=setTimeout(l.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=l.bind(null,s.onerror),s.onload=l.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.j=364,i.p="https://js-agent.newrelic.com/",(()=>{var e={364:0,953:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u {i.r(o);var e=i(3325),t=i(5763);const r=Object.values(e.D);function n(e){const n={};return r.forEach((r=>{n[r]=function(e,r){return!1!==(0,t.Mt)(r,"".concat(e,".enabled"))}(r,e)})),n}var a=i(9144);var s=i(5546),c=i(385),u=i(8e3),d=i(5938),f=i(3960),l=i(50);class h extends d.W{constructor(e,t,r){let n=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,r),this.auto=n,this.abortHandler,this.featAggregate,this.onAggregateImported,n&&(0,u.R)(e,r)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const r=c.il&&!0===(0,t.Mt)(this.agentIdentifier,"privacy.cookies_enabled");let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let t;try{if(r){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,l.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,u.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:r}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await r(this.featureName,"aggregate");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),n(!0)}catch(e){(0,l.Z)("Downloading and initializing ".concat(this.featureName," failed..."),e),this.abortHandler?.(),n(!1)}};c.il?(0,f.b)((()=>o()),!0):o()}shouldImportAgg(r,n){return r!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,"session_trace.enabled")&&(!!n?.isNew||!!n?.state.sessionReplay)}}var g=i(7633),p=i(7894);class m extends h{static featureName=g.t9;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(r,n,g.t9,i),("undefined"==typeof PerformanceNavigationTiming||c.Tt)&&"undefined"!=typeof PerformanceTiming){const n=(0,t.OP)(r);n[g.Dz]=Math.max(Date.now()-n.offset,0),(0,f.K)((()=>n[g.qw]=Math.max((0,p.z)()-n[g.Dz],0))),(0,f.b)((()=>{const t=(0,p.z)();n[g.OJ]=Math.max(t-n[g.Dz],0),(0,s.p)("timing",["load",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var v=i(1117),b=i(1284);class y extends v.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,r,n,i){var o=this.getBucket(e,t,r,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,r){t[e]=w(r,t[e])})),t}(n,o.metrics),o}merge(e,t,r,n,i){var o=this.getBucket(e,t,n,i);if(o.metrics){var a=o.metrics;a.count+=r.count,(0,b.D)(r,(function(e,t){if("count"!==e){var n=a[e],i=r[e];i&&!i.c?a[e]=w(i.t,n):a[e]=function(e,t){if(!t)return e;t.c||(t=x(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=r}storeMetric(e,t,r,n){var i=this.getBucket(e,t,r);return i.stats=w(n,i.stats),i}getBucket(e,t,r,n){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:r||{}},n&&(i.custom=n)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},r="",n=!1,i=0;i t.max&&(t.max=e),e 2&&void 0!==arguments[2])||arguments[2];super(e,r,j.t,n),c.il&&((0,t.OP)(e).initHidden=Boolean("hidden"===document.visibilityState),(0,N.N)((()=>(0,s.p)("docHidden",[(0,p.z)()],void 0,j.t,this.ee)),!0),(0,O.bP)("pagehide",(()=>(0,s.p)("winPagehide",[(0,p.z)()],void 0,j.t,this.ee))),this.importAggregator())}}var P=i(3081);class C extends h{static featureName=P.t9;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,r),this.importAggregator()}}var R,I=i(2210),k=i(1214),H=i(2177),L={};try{R=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(L.console=!0,-1!==R.indexOf("dev")&&(L.dev=!0),-1!==R.indexOf("nr_dev")&&(L.nrDev=!0))}catch(e){}function z(e){try{L.console&&z(e)}catch(e){}}L.nrDev&&H.ee.on("internal-error",(function(e){z(e.stack)})),L.dev&&H.ee.on("fn-err",(function(e,t,r){z(r.stack)})),L.dev&&(z("NR AGENT IN DEVELOPMENT MODE"),z("flags: "+(0,b.D)(L,(function(e,t){return e})).join(", ")));var M=i(6660);class B extends h{static featureName=M.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,M.t,i),this.skipNext=0;try{this.removeOnAbort=new AbortController}catch(e){}const o=this;o.ee.on("fn-start",(function(e,t,r){o.abortHandler&&(o.skipNext+=1)})),o.ee.on("fn-err",(function(t,r,n){o.abortHandler&&!n[M.A]&&((0,I.X)(n,M.A,(function(){return!0})),this.thrown=!0,(0,s.p)("err",[n,(0,p.z)()],void 0,e.D.jserrors,o.ee))})),o.ee.on("fn-end",(function(){o.abortHandler&&!this.thrown&&o.skipNext>0&&(o.skipNext-=1)})),o.ee.on("internal-error",(function(t){(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,o.ee)})),this.origOnerror=c._A.onerror,c._A.onerror=this.onerrorHandler.bind(this),c._A.addEventListener("unhandledrejection",(t=>{const r=function(e){let t="Unhandled Promise Rejection: ";if(e instanceof Error)try{return e.message=t+e.message,e}catch(t){return e}if(void 0===e)return new Error(t);try{return new Error(t+(0,D.P)(e))}catch(e){return new Error(t)}}(t.reason);(0,s.p)("err",[r,(0,p.z)(),!1,{unhandledPromiseRejection:1}],void 0,e.D.jserrors,this.ee)}),(0,O.m$)(!1,this.removeOnAbort?.signal)),(0,k.gy)(this.ee),(0,k.BV)(this.ee),(0,k.em)(this.ee),(0,t.OP)(r).xhrWrappable&&(0,k.Kf)(this.ee),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}onerrorHandler(t,r,n,i,o){"function"==typeof this.origOnerror&&this.origOnerror(...arguments);try{this.skipNext?this.skipNext-=1:(0,s.p)("err",[o||new F(t,r,n),(0,p.z)()],void 0,e.D.jserrors,this.ee)}catch(t){try{(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,this.ee)}catch(e){}}return!1}}function F(e,t,r){this.message=e||"Uncaught error with no additional information",this.sourceURL=t,this.line=r}let U=1;const q="nr@id";function G(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===c._A?0:(0,I.X)(e,q,(function(){return U++}))}function V(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,D.P)(e).length}catch(e){return}}}var X=i(7243);class W{constructor(e){this.agentIdentifier=e,this.generateTracePayload=this.generateTracePayload.bind(this),this.shouldGenerateTrace=this.shouldGenerateTrace.bind(this)}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var r=(0,t.DL)(this.agentIdentifier);if(!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,_.M)(),s=(0,_.Ht)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof c._A?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,D.P)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var r=!1,n={};if((0,t.Mt)(this.agentIdentifier,"distributed_tracing")&&(n=(0,t.P_)(this.agentIdentifier).distributed_tracing),e.sameOrigin)r=!0;else if(n.allowed_origins instanceof Array)for(var i=0;i 2&&void 0!==arguments[2])||arguments[2];super(r,n,Z.t,i),(0,t.OP)(r).xhrWrappable&&(this.dt=new W(r),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee),(0,k.u5)(this.ee),(0,k.Kf)(this.ee),function(r,n,i,o){function a(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener("load",(function(r){_(t,e)}),(0,O.m$)(!1)),c.IF||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,O.m$)(!1))}function s(e){this.params={method:e[0]},T(this,e[1]),this.metrics={}}function u(e,n){var i=(0,t.DL)(r);i.xpid&&this.sameOrigin&&n.setRequestHeader("X-NewRelic-ID",i.xpid);var a=o.generateTracePayload(this.parsedOrigin);if(a){var s=!1;a.newrelicHeader&&(n.setRequestHeader("newrelic",a.newrelicHeader),s=!0),a.traceContextParentHeader&&(n.setRequestHeader("traceparent",a.traceContextParentHeader),a.traceContextStateHeader&&n.setRequestHeader("tracestate",a.traceContextStateHeader),s=!0),s&&(this.dt=a)}}function d(e,t){var r=this.metrics,i=e[0],o=this;if(r&&i){var a=V(i);a&&(r.txSize=a)}this.startTime=(0,p.z)(),this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof t.onload)&&"function"==typeof o.end)&&o.end(t)}catch(e){try{n.emit("internal-error",[e])}catch(e){}}};for(var s=0;s 1?e[1]=i:e.push(i)}else e[0]&&e[0].headers&&s(e[0].headers,n)&&(this.dt=n);function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,p.z)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;"string"==typeof i?r=i:"object"==typeof i&&i instanceof Y?r=i.url:c._A?.URL&&"object"==typeof i&&i instanceof URL&&(r=i.href),T(this,r);var o=(""+(i&&i instanceof Y&&i.method||n.method||"GET")).toUpperCase();this.params.method=o,this.txSize=V(n.body)||0}function A(t,r){var n;this.endTime=(0,p.z)(),this.params||(this.params={}),this.params.status=r?r.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var o={txSize:this.txSize,rxSize:n,duration:(0,p.z)()-this.startTime};i("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,e.D.ajax)}function E(t){var r=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;o 2&&void 0!==arguments[2])||arguments[2];super(e,t,we.t,r),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,_.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(m),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||"agent")),this.start()):(0,l.Z)("Failed to initial the agent. Could not determine the runtime environment.")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t="features";try{const r=n(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,r)=>e.p[t.featureName]-e.p[r.featureName])),i.forEach((t=>{if(r[t.featureName]||t.featureName===e.D.pageViewEvent){const n=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);n.every((e=>r[e]))||(0,l.Z)("".concat(t.featureName," is enabled but one or more dependent features has been disabled (").concat((0,D.P)(n),"). This may cause unintended consequences or missing data...")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,T.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,l.Z)("Failed to initialize all enabled instrument classes (agent aborted) -",e);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,T.fP)();return delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,r.ee?.abort(),delete r.ee?.get(this.agentIdentifier),!1}}}({features:[J,m,S,class extends h{static featureName=oe;constructor(t,r){if(super(t,r,oe,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;const n=this.ee;let i;(0,k.QU)(n),this.eventsEE=(0,k.em)(n),this.eventsEE.on(se,(function(e,t){this.bstStart=(0,p.z)()})),this.eventsEE.on(ae,(function(t,r){(0,s.p)("bst",[t[0],r,this.bstStart,(0,p.z)()],void 0,e.D.sessionTrace,n)})),n.on(ce+ne,(function(e){this.time=(0,p.z)(),this.startPath=location.pathname+location.hash})),n.on(ce+ie,(function(t){(0,s.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,e.D.sessionTrace,n)}));try{i=new PerformanceObserver((t=>{const r=t.getEntries();(0,s.p)(te,[r],void 0,e.D.sessionTrace,n)})),i.observe({type:re,buffered:!0})}catch(e){}this.importAggregator({resourceObserver:i})}},C,xe,B,class extends h{static featureName=de;constructor(e,r){if(super(e,r,de,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;if(!(0,t.OP)(e).xhrWrappable)return;try{this.removeOnAbort=new AbortController}catch(e){}let n,i=0;const o=this.ee.get("tracer"),a=(0,k._L)(this.ee),s=(0,k.Lg)(this.ee),u=(0,k.BV)(this.ee),d=(0,k.Kf)(this.ee),f=this.ee.get("events"),l=(0,k.u5)(this.ee),h=(0,k.QU)(this.ee),g=(0,k.Gm)(this.ee);function m(e,t){h.emit("newURL",[""+window.location,t])}function v(){i++,n=window.location.hash,this[ve]=(0,p.z)()}function b(){i--,window.location.hash!==n&&m(0,!0);var e=(0,p.z)();this[pe]=~~this[pe]+e-this[ve],this[ye]=e}function y(e,t){e.on(t,(function(){this[t]=(0,p.z)()}))}this.ee.on(ve,v),s.on(be,v),a.on(be,v),this.ee.on(ye,b),s.on(ge,b),a.on(ge,b),this.ee.buffer([ve,ye,"xhr-resolved"],this.featureName),f.buffer([ve],this.featureName),u.buffer(["setTimeout"+le,"clearTimeout"+fe,ve],this.featureName),d.buffer([ve,"new-xhr","send-xhr"+fe],this.featureName),l.buffer([me+fe,me+"-done",me+he+fe,me+he+le],this.featureName),h.buffer(["newURL"],this.featureName),g.buffer([ve],this.featureName),s.buffer(["propagate",be,ge,"executor-err","resolve"+fe],this.featureName),o.buffer([ve,"no-"+ve],this.featureName),a.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),y(l,me+fe),y(l,me+"-done"),y(a,"new-jsonp"),y(a,"jsonp-end"),y(a,"cb-start"),h.on("pushState-end",m),h.on("replaceState-end",m),window.addEventListener("hashchange",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){m(0,i>1)}),(0,O.m$)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}],loaderType:"spa"})})(),window.NRBA=o})(); window.jQuery || document.write(' ') CKEDITOR_BASEPATH='https://f1000research.com/js/vendor/ckeditor/' window.reactTheme = 'research'; window.MathJax = { CommonHTML: { linebreaks: { automatic: true } }, 'HTML-CSS': { linebreaks: { automatic: true } }, SVG: { linebreaks: { automatic: true } }, AuthorInit: function() { MathJax.Hub.Register.MessageHook('End Process', function () { let timeout = false; // holder for timeout id const delay = 250; // delay after event is "complete" to run callback const reflowMath = function() { const dispFormulas = document.querySelectorAll('.disp-formula.panel'); if (!dispFormulas) { return; } for (const dispFormula of dispFormulas) { const child = dispFormula.querySelector('.MathJax_Preview').nextSibling.firstChild; const isMultiline = MathJax.Hub.getAllJax(dispFormula)[0].root.isMultiline; if (dispFormula.offsetWidth < child.offsetWidth || isMultiline) { MathJax.Hub.Queue(['Rerender', MathJax.Hub, dispFormula]); } } }; window.addEventListener('resize', function() { clearTimeout(timeout); // clear the timeout timeout = setTimeout(reflowMath, delay); // start timing for event "completion" }); }); }, }; if (window.location.hash == '#_=_'){ window.location = window.location.href.split('#')[0] } !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function() {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)} ;if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '1641728616063202'); fbq('track', "PixelInitialized", {}); (function(h,o,t,j,a,r){ h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)}; h._hjSettings={hjid:2318163,hjsv:6}; a=o.getElementsByTagName('head')[0]; r=o.createElement('script');r.async=1; r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv; a.appendChild(r); })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv='); search file_upload Submit your research search menu close search Browse Gateways & Collections How to Publish Submit your Research My Submissions Article Guidelines Article Guidelines (New Versions) Open Data, Software and Code Guidelines Open Data and Accessible Source Materials Guidelines (HSS) Open Data, Software and Code Guidelines (PSE) Prepublication Checks Production Process Posters and Slides Guidelines Document Guidelines Article Processing Charges Peer Review Finding Article Reviewers About How it Works For Reviewers Our Advisors Policies Glossary FAQs For Developers Newsroom Contact My Research Submissions Content and Tracking Alerts My Details Sign In file_upload Submit your research { "@context": "https://schema.org", "@type": "ScholarlyArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://f1000research.com/articles/13-138" }, "headline": "Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for...", "datePublished": "2024-02-22T14:11:41", "dateModified": "2024-02-22T14:11:41", "author": [ { "@type": "Person", "name": "Amitha Shetty" }, { "@type": "Person", "name": "Akhilesh Dubey" }, { "@type": "Person", "name": "Jeshma Chrystle" }, { "@type": "Person", "name": "Manohar M" }, { "@type": "Person", "name": "Anish John" }, { "@type": "Person", "name": "Amitha N" }, { "@type": "Person", "name": "Paramita Das" }, { "@type": "Person", "name": "Srinivas Hebbar" } ], "publisher": { "@type": "Organization", "name": "F1000Research", "logo": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 480, "width": 60 } }, "image": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 1200, "width": 150 }, "description": " Background Curcumin, known for its anti-inflammatory properties, was selected for the developing consumer friendly film forming spray that offers precise delivery of curcumin and and improves patient adherence. Methods An optimized film-forming solution was prepared by dissolving curcumin (1%), Eudragit RLPO (5%), propylene glycol (1%), and camphor (0.5%) in ethanol: acetone (20:80) as the solvent. The solution was filled in a spray container which contained 70% solutions and 30% petroleum gas. In-vitro characterization was performed. Results Potential anti-inflammatory phytoconstituents were extracted from the PubChem database and prepared as ligands, along with receptor molecules (nsp10-nsp16), for molecular docking using Autodock Vina. The docking study showed the lowest binding energy of -8.2 kcal/mol indicates better binding affinities. The optimized formulation consisted of ethanol:acetone (20:80) as the solvent, Eudragit RLPO (5%) as the polymer, propylene glycol (1%) as the plasticizer, and camphor oil (0.5%) as the penetration enhancer. The optimized formulation exhibited pH of 5.8 ± 0.01, low viscosity, low film formation time (19.54 ± 0.78 sec), high drug content (8.243 ± 0.43 mg/mL), and extended ex vivo drug permeation (85.08 ± 0.09%) for nine hours. Consequently, the formulation was incorporated into a container using 30% liquefied petroleum gas, delivering 0.293 ± 0.08 mL per actuation, containing 1.53 ± 0.07 mg of the drug. The film-forming spray exhibited higher cumulative drug permeation (83.94 ± 0.34%) than the marketed cream formulation and pure drug solution after 9 h, with an enhancement ratio of 14. Notably, the film-forming spray exhibited no skin irritation and remained stable for over three months. Conclusions The developed curcumin film-forming system is promising as a carrier for wound management because of its convenient administration and transport attributes. Further in vivo studies are required to validate its efficacy in wound management. " } { "@context": "http://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": "1", "item": { "@id": "https://f1000research.com/", "name": "Home" } }, { "@type": "ListItem", "position": "2", "item": { "@id": "https://f1000research.com/browse/articles", "name": "Browse" } }, { "@type": "ListItem", "position": "3", "item": { "@id": "https://f1000research.com/articles/13-138", "name": "Fabrication and in vitro characterization of curcumin film-forming..." } } ] } Home Browse Fabrication and in vitro characterization of curcumin film-forming... ALL Metrics - Views Downloads Get PDF Get XML Cite How to cite this article Shetty A, Dubey A, Chrystle J et al. Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy [version 1; peer review: 3 approved] . F1000Research 2024, 13 :138 ( https://doi.org/10.12688/f1000research.142860.1 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. Close Copy Citation Details Export Export Citation Sciwheel EndNote Ref. Manager Bibtex ProCite Sente EXPORT Select a format first Track Share ▬ ✚ Research Article Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy [version 1; peer review: 3 approved] Amitha Shetty 1 , Akhilesh Dubey 1 , Jeshma Chrystle 1 , [...] Manohar M 1 , Anish John 1 , Amitha N 1 , Paramita Das 2 , Srinivas Hebbar https://orcid.org/0000-0002-2459-4937 3 Amitha Shetty 1 , Akhilesh Dubey 1 , [...] Jeshma Chrystle 1 , Manohar M 1 , Anish John 1 , Amitha N 1 , Paramita Das 2 , Srinivas Hebbar https://orcid.org/0000-0002-2459-4937 3 PUBLISHED 22 Feb 2024 Author details Author details 1 Department of Pharmaceutics, Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences, Deralakatte, Mangalore, Karnataka, 575018, India 2 Department of Pharma chemistry, Krupanidhi College of Pharmacy, Bangaluru, Karnataka, 560035, India 3 Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India Amitha Shetty Roles: Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Resources, Visualization, Writing – Review & Editing Akhilesh Dubey Roles: Conceptualization, Data Curation, Investigation, Methodology, Project Administration, Resources, Software, Supervision, Validation, Visualization, Writing – Review & Editing Jeshma Chrystle Roles: Conceptualization, Data Curation, Formal Analysis, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Manohar M Roles: Conceptualization, Data Curation, Formal Analysis, Writing – Review & Editing Anish John Roles: Conceptualization, Data Curation, Formal Analysis, Writing – Review & Editing Amitha N Roles: Data Curation, Formal Analysis, Writing – Review & Editing Paramita Das Roles: Data Curation, Software, Supervision, Writing – Review & Editing Srinivas Hebbar Roles: Data Curation, Funding Acquisition, Investigation, Methodology, Supervision, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing OPEN PEER REVIEW DETAILS REVIEWER STATUS This article is included in the Manipal Academy of Higher Education gateway. Abstract Background Curcumin, known for its anti-inflammatory properties, was selected for the developing consumer friendly film forming spray that offers precise delivery of curcumin and and improves patient adherence. Methods An optimized film-forming solution was prepared by dissolving curcumin (1%), Eudragit RLPO (5%), propylene glycol (1%), and camphor (0.5%) in ethanol: acetone (20:80) as the solvent. The solution was filled in a spray container which contained 70% solutions and 30% petroleum gas. In-vitro characterization was performed. Results Potential anti-inflammatory phytoconstituents were extracted from the PubChem database and prepared as ligands, along with receptor molecules (nsp10-nsp16), for molecular docking using Autodock Vina. The docking study showed the lowest binding energy of -8.2 kcal/mol indicates better binding affinities. The optimized formulation consisted of ethanol:acetone (20:80) as the solvent, Eudragit RLPO (5%) as the polymer, propylene glycol (1%) as the plasticizer, and camphor oil (0.5%) as the penetration enhancer. The optimized formulation exhibited pH of 5.8 ± 0.01, low viscosity, low film formation time (19.54 ± 0.78 sec), high drug content (8.243 ± 0.43 mg/mL), and extended ex vivo drug permeation (85.08 ± 0.09%) for nine hours. Consequently, the formulation was incorporated into a container using 30% liquefied petroleum gas, delivering 0.293 ± 0.08 mL per actuation, containing 1.53 ± 0.07 mg of the drug. The film-forming spray exhibited higher cumulative drug permeation (83.94 ± 0.34%) than the marketed cream formulation and pure drug solution after 9 h, with an enhancement ratio of 14. Notably, the film-forming spray exhibited no skin irritation and remained stable for over three months. Conclusions The developed curcumin film-forming system is promising as a carrier for wound management because of its convenient administration and transport attributes. Further in vivo studies are required to validate its efficacy in wound management. READ ALL READ LESS Keywords film-forming spray, curcumin, design of experiment, docking study, permeation, stability study Corresponding Author(s) Srinivas Hebbar ( [email protected] ) Close Corresponding author: Srinivas Hebbar Competing interests: No competing interests were disclosed. Grant information: The author(s) declared that no grants were involved in supporting this work. Copyright: © 2024 Shetty A et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. How to cite: Shetty A, Dubey A, Chrystle J et al. Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy [version 1; peer review: 3 approved] . F1000Research 2024, 13 :138 ( https://doi.org/10.12688/f1000research.142860.1 ) First published: 22 Feb 2024, 13 :138 ( https://doi.org/10.12688/f1000research.142860.1 ) Latest published: 22 Feb 2024, 13 :138 ( https://doi.org/10.12688/f1000research.142860.1 ) Introduction A wound is an abrupt or gradual loss of skin or tissue integrity that causes inflammation and the entry of pathogens into the body. Wounds must heal rapidly to reduce the risk of infection and restore the functional status of the skin. In general, the healing process of a wound lasts from 8 to 12 weeks; however, for chronic wounds, it may take years. The natural wound healing process has four distinct phases: hemostasis followed by inflammatory phases. Within a few hours of injury, a new epithelium begins to develop, including the growth of new blood vessels, collagen fiber implantation, and granulation tissue production. The production of collagen is stimulated, as well as collagen reassembly and the development of scar tissue, in the final stage of wound healing. 1 The currently available products function in wound healing in terms of antimicrobial agents, anti-inflammatory agents, and certain drugs that promote cell proliferation to repair damaged cells. The importance of herbal-based drug delivery systems has significantly increased in recent years. World Health Organization (WHO) estimates that more than 80% of people worldwide depend on traditional medical practices for primary healthcare. The use of phytoconstituents such as curcumin, silymarin, and quercetin has expanded over the years because of the escalating cost of drugs and the side effects of synthetic agents. 2 Curcumin is a polyphenolic constituent obtained from the rhizomes of Curcuma longa (turmeric) belonging to the family Zingiberaceae. As per the Indian Ayurvedic medicinal system, Curcuma longa and its constituents are widely used in several dosage forms for various disease conditions. According to other studies, polyphenol curcumin possesses potent antioxidant, antimicrobial and anti-inflammatory properties, and it is involved in re-epithelization by enhancing fibroblast proliferation. 3 The anti-inflammatory properties of curcumin inhibited the production of two significant cytokines, tumor necrosis alpha and interleukin -1. Upon topical administration, the antioxidant property of curcumin has been shown to drastically reduce wound healing time by scavenging free reactive oxygen molecules such as hydrogen peroxide (H202) and superoxide (O2-). 4 Additionally, Mohanty et al . demonstrated that a transdermal patch with curcumin-loaded oleic acid promoted granulation of new tissue and fibroblast infiltration within a week of application compared to the control group of animals. 5 Despite these benefits, curcumin has significant limitations, such as poor aqueous solubility, a higher rate of elimination, and faster degradation. Therefore, topical product formulations aim to solubilize curcumin while protecting it from hydrolysis and ensuring its prolonged release into the target location. One disadvantage of topical curcumin is that toxicity at the wound site can occur at high concentrations. Therefore, the optimal concentration of the formulation was selected. 6 Superficial and shallow wounds were effectively treated with polymeric films composed of transparent polyurethanes. Transparent films enable the exchange of carbon dioxide and oxygen between the wound and the environment, while protecting the site from microbial contamination. 7 The film can be developed by spraying drug-polymer mixtures onto the skin as a patient-friendly method compared to gels and ointments. The advantages of film-forming spray over conventional topical formulations are a uniform distribution of the drug, lower irritation, improved wound healing by controlling moisture, and continuous spraying, which enhances the mechanical properties of the polymeric film. 8 The nature of the polymer, nozzle type, spray pressure, and other variables can affect the spray pattern. Various film-forming sprays are available, such as ordinal spray, metered-dose spray, electrostatic spray, and ultrasonic spray. In recent years, the discovery of new therapeutic agents has become simpler through the application of computer-assisted approaches. Determining the possible molecular interactions for selective binding between a drug and protein receptors is made easier using molecular docking techniques. These prospective approaches provide promising results at shorter intervals. 9 In the present study, curcumin compounds were analysed using in silico methods to assess their possible inhibitory activities against the nsp10-nsp16 receptor. However, in vitro in vivo methodologies are required to authenticate drug properties. The objective of this in vitro study was to develop and assess a polyphenol curcumin-based film-forming spray intended to efficiently treat wounds. Methods Materials Curcumin was acquired from Sigma-Aldrich Chemicals Pvt. Ltd. (>94% purity) (Bangalore, India). Eudrgait S100, Eudrgait RS100, Eudrgait E100, PVP K30, Carbopol 934-P, PEG 400, propylene glycol, camphor oil, dibutyl phthalate, menthol, ethanol, and acetone were purchased from Loba Chemie Pvt. Ltd. (Mumbai, India). Transcutol P was obtained from Nice Chemical Pvt. Ltd. (Kerala, India). All other chemicals and reagents used were of analytical grades. Laboratory animals The NGSM Institute of Pharmaceutical Sciences Institutional Animal Ethics Committee (IAEC) approved the purchase of adult male Wistar rats weighing approximately 200–250 g from the Nitte University-affiliated Centre for Animal Research and Experimentation (NUCARE) (Approval No. NGSM/IAEC/2021-22/240 dated 28 th June 2021). Experiments were conducted in accordance with the Committee for Control and Supervision Experiments on Animals (CPCSEA) rules, experiments were conducted. All efforts were made to ameliorate any suffering of animals by the application of methylated spirit as an antiseptic to prevent infection and careful, gentle handling to minimize distress. The nine animals allocated to three groups of three animals each were maintained in a cage, with the optimum conditions of 25 ± 2°C, 50 ± 1% relative humidity (RH), and 12-hour light/dark intervals with regular feeding, including water and pellet food (Krishna valley Aggrotech, Sangli, Maharashtra, India). Ligand preparation and molecular docking Ligand preparation and molecular docking from PubChem database chemical structures of potential phytoconstituents with anti-inflammatory properties, namely both ligand and receptor molecules (nsp10–nsp16), were prepared in Autodock software (version number 4.2.0) to predict the target receptor by performing blind docking. A grid of 60 points each in the X, Y, and Z directions was chosen to accommodate any possible ligand-receptor complex using a blind docking approach. The graphical user interface of the PyMOL tool (version number 2.5) was used to visualize the structure files, and the protein-ligand interaction was prepared in Biovia Discovery Studio (2021). 10 Screening of solvents Solvents such as ethanol, isopropyl myristate, ethyl acetate, propylene glycol, oleic acid, and acetone were used to determine the solubility of curcumin in these solvents. Excess curcumin was dissolved in 100 mL of each solvent and kept in a shaking water bath for 48 h. After 48 h, the solvents were centrifuged for 15 mins at 3000 rpm. From the centrifuged sample, 1 mL was taken, diluted to 10 mL with the respective solvents, and spectrophotometrically determined at 426 nm. 11 Screening of polymers Polymers such as Eudragit RS100, Eudragit RLPO, Eudragit S100, Eudragit E100, PVP K-30, Carbopol 934-P, and PEG 400 were selected for the study. A film-forming solution was prepared using 1% curcumin and 5% polymer in ethanol: acetone (20:80), respectively, and was evaluated for viscosity, drying time, and stickiness. 12 Screening of plasticizers Plasticizers, such as PEG 400, propylene glycol, and dibutyl phthalate, were selected for this study. The polymeric solvent system was prepared by dissolving 1% curcumin and 5% Eudragit RLPO in ethanol:acetone (20:80), respectively. Subsequently, plasticizers (0.75%) were added to the previously prepared polymeric solvent system and further evaluated for flexibility. 13 Screening of penetration enhancers Penetration enhancers, such as camphor, menthol, and Transcutol P, were selected for this study. The polymeric solvent system was prepared to comprise 1% curcumin, 5% Eudragit RLPO, and 0.75% propylene glycol in ethanol:acetone (20:80), and 0.75% of each penetration enhancer, which was then evaluated for ex vivo permeation studies, flux, and enhancement ratio. 14 Optimization by Design of Experiment The impact of selected independent variables including concentration of polymer (A), concentration of plasticizers (B), and concentration of penetration enhancers (C), and the dependent variables included film formation time (s) and ex vivo permeation studies (%). The experimental conditions were optimized using Design Expert software (Version 13.0.3.0, Stat-Ease, Minneapolis, MN 55413, USA) employing central composite design (CCD). An open-access alternative that can perform an equivalent function is R commander . The levels at which the independent variables were selected are listed in Table 1 . 15 The variable levels were optimized based on the desirability function approach. As shown in Table 2 , appropriate constraint (target) levels were chosen to achieve the desired responses of the formulation. Table 1. Independent and dependent factors selected and levels for the experiment. Independent factors Name level Level (-1) Level (0) Level (+1) A Concentration of polymer 2.5 5 7.5 B Concentration of plasticizer 0.5 0.75 1 C Concentration of penetration enhancer 0.5 0.75 1 Dependent factors X1 Film formation time X2 Ex vivo permeation studies Table 2. Criteria for numerical optimization and optimized formula. Name Goal Lower limit Upper limit Lower weight Upper weight Importance A: Concentration of polymer is in range 2.5 7.5 1 1 3 B: Concentration of plasticizer is in range 0.5 1 1 1 3 C: Concentration of penetration enhancer is in range 0.5 1 1 1 3 Film formation time is target = 20 18.2 49.73 1 1 3 % cumulative drug permeation is target = 85 65.08 89.64 1 1 3 Optimized formulation Concentration of polymer Concentration of plasticizer Concentration of penetration enhancer Desirability 5% 1% 0.5% 0.98 Formulation of optimized film-forming solution As per the optimized formula obtained after optimization, the optimized film-forming solution was prepared by dissolving curcumin (1%), Eudragit RLPO (5%), propylene glycol (1%), and camphor (0.5%) in ethanol:acetone (20:80) as the solvent. Characterization of optimized film-forming solution Viscosity Viscosity assessment of the film-forming solution was assessed at a controlled temperature of 25 ± 1°C using a Brookfield viscometer (DV-11 +pro). A specific spindle (S 63) was used, and measurements were taken at different rotational speeds (10, 50, and 100 rpm) for 10 min. This systematic evaluation aimed to determine the viscosity limits suitable for the sprayability of a solution, which is an essential characteristic for its practical application. Each viscosity measurement was performed in triplicates. 16 Film formation time The film formation time, a critical parameter for ensuring patient compliance, was assessed by placing a minute quantity of the film-forming solution onto a petri dish. The time taken for the solution to transform into a fully formed dry film was carefully observed and recorded. This evaluation aimed to determine the time required for the film-forming process, which is a crucial factor for the convenience and usability of the formulation for patients. Among the various formulations, preference was given to those that exhibited shorter drying times, as they offered quicker film development, potentially enhancing patient comfort and adherence. 17 Each measurement was performed thrice. Stickiness The stickiness evaluation involved gently placing a piece of cotton onto each dried film without applying any pressure. The degree of stickiness was determined based on the extent of cotton fibre retention on the film’s surface: films with a greater amount of retained cotton fibers were categorized as “very sticky,” films with a moderate level of retained fibers were classified as “medium sticky,” and films with no adherence of cotton fibers were considered “non-sticky.” This approach provides a practical and visual means of distinguishing between different levels of stickiness, systematically facilitating characterization of the adhesive properties of the films. 18 pH determination The pH of the film-forming solution was determined using a digital pH meter (Systronics, Ahmedabad, India). The pH meter electrode was submerged in the film-forming solution, and the pH value was directly recorded from the meter’s display. 19 Drug content studies The drug content was carried out to determine the distribution of the drug in the film-forming patch. A 2 cm patch was cut, dissolved in 5 mL methanol, and made up to a volume of 10 mL using phosphate buffer (pH 7.4) (1st dilution). From this dilution, 1 mL was pipetted into another 10 mL volumetric flask, and the volume was made using phosphate buffer (pH 7.4). Drug content was estimated spectrophotometrically using a UV-visible spectrophotometer at 426 nm. 20 Ex vivo permeation study Drug permeation from the subcutaneous layer of the skin was assessed using porcine ear pinna skin, because the porcine ear skin membrane morphology is similar to that of human skin using Franz diffusion cells. Skin was bought from the slaughterhouse and preserved in phosphate-buffered saline (pH 7.4) at room temperature. The hair present in the skin was gently removed and dipped in hot water for 15 min to remove any subcutaneous fatty layer. The excised skin was mounted between the donor and receptor compartments of the diffusion cell apparatus with effective permeation area of 3.14 cm 2 and the formulation being applied on the stratum corneum facing outward of the donor compartment and the Phosphate buffer with pH 7.4 as receptor medium. A weighed amount of the formulation equivalent to 20 mg of the drug was placed on the surface of the skin. The dissolution medium was mixed using a magnetic stirrer at 50 rpm, and the temperature was maintained at 37 ± 0.5°C to simulate external skin conditions using a water bath. A sample of 1 mL was withdrawn at predetermined time intervals (0, 1, 2, 3, 4, 5, 6, 7, 8, and 9 h). The sink condition was maintained by replacing the sink with the same amount of saline buffer. One millilitre of the withdrawn sample was dissolved in 10 mL of phosphate-buffered saline (pH 7.4) in a volumetric flask. Absorbance was measured using a UV-visible spectrophotometer at 426 nm. The cumulative amount of drug that permeated (%) through the skin was plotted versus time (h). Data are expressed as the mean ± standard deviation (SD) of three determinations. This study assessed and compared the transdermal permeation capabilities of an in-house pure curcumin drug solution, film-forming spray formulation, and commercially available cream. 21 Permeation data analysis The experimental determination of permeation parameters involved calculating the skin flux (J) in μg/cm 2 /h using Equation (1) , derived from the slope of the linear segment in the plot of cumulative amount permeated per unit area against time. The skin flux (J) can be experimentally determined using the formula (1) J = dQ / dt / A where ‘J’ represents the flux (μg/cm 2 /h), ‘A’ is the area of skin tissue (cm 2 ) through which drug permeated, and (dQ/dt) is the slope obtained from the linear curve of the plot- cumulative amount permeated per unit area versus time. Subsequently, the permeability coefficient (Kp) (cm/h) was calculated using equation (2) in which ‘C 0 ’ indicate the drug concentration in the donor cell. The enhancement ratio (ER) using the following equation 3 . The permeation parameters were calculated using these previously reported equations 22 (2) Kp = J C 0 (3) ER = Kp with penetration enhancer Kp without penetration enhancer Verification of optimization The predicted results from the optimization were compared with the experimental values were compared and the relative percentage error was determined. Filling of film-forming solution into the container The process of filling the container with film-forming solutions involved the application of a pressure-filling method. This procedure employed 70% of the film-forming solution and 30% of liquefied petroleum gas as the propellant. This precise mixture was introduced into the container to ensure controlled and efficient filling. The developed formulation is illustrated in Figure 1 . Figure 1. Film-forming spray of curcumin. Evaluation parameters related to the container The delivery volume per actuation The formulation delivered per actuation was measured using the following formula: (4) AL Wo – Wt Dn Where AL represents the volume of the solution delivered per actuation, Wo and Wt is the weight of the formulation before and after actuation, and Dn is the density of the formulation. The measurements were made in triplicates and the results were expressed as mean ± SD. 23 Spray pattern The formulation was sprayed onto Whattmann paper positioned at a predetermined distance. This paper was securely fastened to a board to create a stable platform for the experiment. The spray formulations were discharged from the container at a distance of 15 cm from the paper surface. This standardized procedure allowed for the observation and assessment of the resultant spray pattern on paper. By conducting this test, the uniformity and spread of the spray could be visually examined and analysed for consistency and effectiveness. 24 Spray angle The sprays were actuated horizontally on white paper mounted 15 cm from the nozzle. The radius of the circle formed on the paper was recorded in triplicate from different directions. The spray angle (θ) is calculated using the following equation: (5) Spray angle θ = tan − 1 l / r where l is the distance of the paper from the nozzle and r is the average radius of the circle. 25 Skin irritation studies The protocol for the present study (Ref: NGSM/IAEC/2021-22/240) was approved by the Institutional Animal Ethics Committee (IAEC). A skin irritation study was conducted in male Wistar rats to ensure product safety. Inclusion and exclusion criteria for animals included factors such as the health status, age, weight, of either sex were considered. Nine healthy male Wistar rats weighing between 200–250 gm were included based on a thorough literature survey, aligning with ethical guidelines to use the minimum animals necessary while ensuring statistical robustness. The sample size was determined according to the available literature, as the study did not consider a specific primary outcome measure for hypothesis testing, and therefore no a priori sample size calculation was conducted. Nine Wistar rats were divided into three groups, with three rats in each group: Group I (control, placebo spray), Group II (standard, drug in solvent), and Group III (film-forming formulation). They were caged separately according to their groups and provided with food, water, and proper environmental conditions. Twenty-four hours before the application, the hair on the dorsal side (3 × 3 cm) of the male Wistar rats was removed using an electric clipper in the direction of the tail to the head without damaging the skin, and the methylated spirit was then applied as an antiseptic to the shaved region with the aid of cotton wool to prevent infection caused by bacteria. As only skin irritation studies were carried out on the dorsal surface, animals were not euthanised. The formulations were applied to the depilated areas of the animals in each group. Exclusion criteria included any signs of pre-existing skin conditions or illness. For data points, criteria for inclusion or exclusion involved the presence of observable skin irritation reactions. Humane endpoints were based on the observations such as presence of severe irritation, ulceration, and significant behavioural changes. If these conditions transpired, the animals were excluded from the study with immediate implementation to minimize suffering. Skin irritation was observed according to the OECD guidelines at predetermined intervals three times daily. At the end of 24 h, the skin surface was rinsed with distilled water and graded if edema was observed. Wistar rats were re-caged, and post-procedure observation (i.e., scoring) was repeated for seven days. Based on the scoring, the formulated films were graded as non-irritant, irritant, or highly irritant. 26 , 27 Stability studies of formulation The formulated film-forming spray was kept for stability investigation according to International Council for Harmonisation (ICH) guidelines [Q1A, R2] for six months at 40°C ± 2 and relative humidity of 75 ± 2%. The study conditions were maintained in a stability chamber (Photostability Chamber, Rotek). At three months, samples were taken to determine the film-formation time, pH, volume delivered upon each actuation, and drug content per actuation. The samples were assessed in triplicate [n = 3]. 28 Statistical analysis The results are presented as mean ± SD. The experiments were performed in triplicate. A t-test and one-way ANOVA were used for statistical analysis to determine significant differences between the means tested (p <0.05), applying Sidak’s multiple comparisons test to assess the differences between groups. All calculations were completed using Graphpad Prism 10 (GraphPad Inc., La Jolla, CA, USA). An open-access alternative that can perform an equivalent function is JASP . Results Docking analysis In this study, in-silico docking tools were employed to validate the viability of selected curcumin molecules with respect to their interactions with the target protein (nsp10-nsp16), considering a variety of conformations and binding energies. A comprehensive understanding of binding dynamics was obtained by scrutinizing multiple conformations, shown in Figure 2 . This multifaceted approach revealed a spectrum of binding energies, providing insights into the strength of the interactions between the curcumin molecules and the receptor. Curcuminoids in turmeric exhibited the most favorable binding energy among the studied molecules, with a remarkable value of -8.2 kcal/mol. This outcome underscores the potential of curcumin as a potent ligand for target proteins. Through its interactions with the receptor, curcumin establishes hydrogen bonds with key residues, including ASP:135, GLN:327, CYS:47, LEU:152, and ARG:469, contributing to its robust binding affinity. A crucial indicator of the efficacy of the ligand-receptor interaction is the calculated change in Gibbs free energy (ΔG). In the context of this study, the lower value of ΔG associated with curcumin underscores its enhanced binding affinity to the target protein. This implies a more stable and robust interaction, reinforcing the potential therapeutic relevance of curcumin. 29 Thus, the computational docking study offers valuable insights into the molecular-level interactions between curcumin and the nsp10-nsp16 receptor. Figure 2. Molecular docking analysis of curcumin. Screening of solvents The solvent used to suspend a drug has the potential to exert a significant impact on the thermodynamic activity of the drug itself. This can lead to increased drug penetration into the subcutaneous layer, subsequently facilitating the achievement of a more substantial concentration of the drug at the topical application site. 30 Hence, various solvents, including ethanol, isopropyl alcohol, ethyl acetate, propylene glycol, oleic acid, and acetone, were systematically assessed for compatibility with curcumin. Notably, among the solvents tested, ethanol and acetone demonstrated the highest solubility for curcumin. Owing to the lone pair of oxygen atom electrons in its molecular structure, curcumin forms hydrogen bonds that allow it to dissolve in organic solvents. 31 Therefore, different ethanol/acetone ratios (20:80, 50:50, and 80:20) were used to determine the concentration. The solvent with the highest concentration was ethanol: acetone, taken in a ratio of 20:80, and thus was selected as the best solvent for further studies ( Figure 3 ). Figure 3. Solubility assessment of curcumin in various oils. Screening of polymers In the current study, the screening process for polymers revolved around critical attributes, including viscosity, drying time, and stickiness, as listed in Table 3 . Often regarded as a crucial determinant, viscosity leans towards lower values for spray-based film formation, enabling accurate and adaptable dosing strategies. In this context, the formulations were thoroughly evaluated to assess viscosity, yielding a spectrum ranging from 0.21 to 2.9 cps. Consequently, solutions with lower viscosities were developed for further consideration. Drying time, another parameter, underpins the efficacy of film-forming solutions. Swift drying times, typically within the range 3–4 minutes, are preferred to prevent extended waiting periods for patients. To ascertain this, the formulations were subjected to drying time evaluations spanning from 10 s to 10 min. Subsequent analysis led to the selection of solutions with the shortest drying times, effectively avoiding prolonged patient waiting intervals. 32 Moreover, an imperative criterion involves the adherence potential of the prepared film-forming solutions, which necessitates minimal stickiness to avert undesired interactions with clothing or surfaces. The assessment of stickiness rendered a diverse spectrum, encompassing solutions ranging from least sticky to markedly adhesive solutions. Consequently, solutions characterized by reduced stickiness were identified as successful candidates, warranting further investigation. 33 An intriguing observation was made within the conducted investigations regarding Carbopol 934-P, which displayed an exceptionally rapid drying time of 10 ± 0.31s owing to its inherent hydrophilic nature. However, this was accompanied by a moderate level of stickiness. In contrast, Eudragit RLPO exhibited a marginally extended drying time of 11 ± 0.03s while remaining non-sticky, which rendered it particularly favorable. As a result, Eudragit RLPO emerged as the preferred polymer for film-forming spray formulation. Table 3. Screening of polymers based on viscosity, drying time, and stickiness. Polymers (5%) RPM Drying time (Seconds) Stickiness Viscosity Eudragit RLPO 10 50 100 11 ± 0.03 + 0.4 ± 0.01 0.37 ± 0.16 0.21 ± 0.27 Eudragit E100 10 50 100 45 ± 0.01 + 0.76 ± 0.37 0.54 ± 0.12 0.53 ± 0.09 Eudragit RS100 10 50 100 50 ± 0.71 + 0.67 ± 0.32 0.55 ± 0.19 0.31 ± 0.08 Eudragit S100 10 50 100 28.75 ± 0.12 + 0.74 ± 0.41 0.65 ± 0.17 0.27 ± 0.05 PVP K- 30 10 50 100 60 ± 0.41 +++ 2.9 ± 0.26 2.4 ± 0.38 1.90 ± 0.49 Carbopol 934-P 10 50 100 10 ± 0.31 ++ 0.78 ± 0.29 0.33 ± 0.02 0.23 ± 0.07 PEG 400 10 50 100 300 ± 0.03 + 0.9 ± 0.27 0.6 ± 0.11 0.4 ± 0.38 Screening of plasticizers Plasticizers contribute to improved film-forming solution flexibility, and thus reduce the brittleness, cracking, and flaking of the film. The plasticizers selected were PEG 400, propylene glycol, and dibutyl phthalate. Dibutyl phthalate was not considered because it was not sufficiently flexible, was very sticky, and did not form an even patch. PEG 400 and propylene glycol (0.75%) were evaluated based on flexibilities. The propylene glycol films were found to be more flexible than PEG 400. Screening of penetration enhancers The complex arrangement of the intercellular lipid layers is a major barrier to transdermal drug penetration. The drug diffusion process begins, and the interaction between the permeation enhancer and skin lipids influences its solubility. 34 The stratum corneum, sweat glands, or hair follicles are all involved in the process used by penetration enhancers to allow drugs to get through. The penetration enhancers selected were camphor, menthol, and Transcutol P at a concentration of 0.75% each. They were evaluated based on the ex vivo drug permeation, flux, permeability coefficient, and enhancement ratio. The addition of Transcutol P to the solution resulted in turbidity and increased viscosity; thus, it was not considered for further studies. Camphor 0.75% demonstrated statistically significant maximum drug permeation of 85.60 ± 0.32% after nine hours, with a flux value of 7.41 ± 0.17 μg/cm 2 /hr and a permeability coefficient of 0.37 ± 0.05 cm 2 /hr, compared to menthol (p < 0.05) with an enhancement ratio of 18.5 as depicted in Figure 4 and Table 4 . Therefore, camphor was selected as the best penetration enhancer in this study. Figure 4. Cumulative drug release from various penetration enhancers. The data presented are the mean ± standard deviation (n = 3). Significance was measured by One-way ANOVA. ** indicates the significance between camphor and without penetration enhancer (p < 0.005), and *indicates the significance between camphor and menthol (p < 0.05). Table 4. Screening of penetration enhancers based on permeation data analysis. Parameters Without penetration enhancer Camphor Menthol Flux (μg/cm 2 /hr) 0.47 ± 0.13 7.41 ± 0.17 6.11 ± 0.14 Permeability coefficient (cm 2 /hr) 0.02 ± 0.01 0.37 ± 0.05 0.30 ± 0.12 Enhancement ratio - 18.5 15.0 Optimization by Design of Experiment The formulation was optimized using 2 3 levels of factorial randomized central composite design using the Design Expert software. Seventeen trial batches were prepared and evaluated for film formation time and ex vivo drug permeation. The film formation time and ex vivo drug permeation studies were 18.20–49.73 secs and 65.08–89.64%, respectively ( Table 5 ). Table 5. Skin irritation study. Groups Type Parameter Primary irritation index Erythema Edema Group I Control group - - - Group II Standard group - - + Group III Film-forming spray - - - Impact of selected variables on film formation time The p-value <0.0001 and an F-value of 69.71 indicated that the quadratic model for film formation time was significant. The non-significant lack of fit, (p = 0.5471), suggested the appropriateness of the model for predicting film formation time. the contour plot and response surface plot ( Figure 5 ), indicated that the film formation time was substantially increased with increase in the concentrations of polymer, plasticizer, and permeation enhancer from -1 to +1 levels. Figure 5. Contour plot and response surface plot of film formation time. The impact of selected factors on the film formation time is shown in the following equation: (6) Film formation time = + 32.67 + 6.29 A + 8.20 B + 1.61 C − 0.6063 AB + 0.3712 AC + 0.3412 BC − 1.67 A 2 + 2.87 B 2 + 0.0494 C 2 A, B, and C represent the coded values for the polymer, plasticizer, and penetration enhancer concentrations, respectively. Impact of selected variables on ex vivo drug permeation studies The p-value of 0.0036 and an F-value of 9.53 indicated that the quadratic model for ex-vivo drug permeation studies was significant. The non-significant lack of fit, ( p =0.1455), indicated that the appropriateness of the model for ex-vivo drug permeation studies. The contour plot and response surface plot ( Figure 6 ) indicated significant increase in ex-vivo drug permeation with an increase in both polymer and plasticizer concentrations from -1 to +1 level. However, as the penetration enhancer increased from 0.5% to 1%, the ex vivo drug permeation studies decreased. These factors significantly affected ex vivo drug permeation studies, as shown in the following equation: (7) Film formation time = + 81.34 + 0.9780 A + 1.13 B − 3.50 C − 0.8175 AB + 1.33 AC − 0.1700 BC − 10.69 A 2 − 0.0613 B 2 + 1.17 C 2 Figure 6. Contour plot and response surface plot of ex vivo drug permeation. A, B, and C represent the coded values for the polymer, plasticizer, and penetration enhancer concentrations, respectively. The criteria for numerical optimization and the optimized formulation based on Design Expert software are presented in Table 2 . Characterization of optimized film-forming solution The pH, viscosity, film formation time, drug content, and ex-vivo permeation studies were performed as described in the methods section. The results are shown in Table 6 . The colour and appearance of the optimized film-forming solutions were then evaluated. The physical appearance of the film-forming solution was dark yellow and transparent. The evaluation of pH is a crucial parameter for topical formulations, as it can cause skin irritation if it differs from standard skin pH conditions (i.e., 4 to 6). The pH was 5.8 ± 0.01, closer to the skin pH. Therefore, the curcumin film-forming solution may not irritate the skin while administered topically and also helps in the ionization of the drug into the permeation process. The viscosity of the optimized film-forming solution was 2.268 cps, which ensured accurate and flexible dosing because viscosity is inversely proportional to the number of polymers utilized; a higher viscosity results in less spray coverage. Table 6. pH, viscosity, film formation time, and drug content of the optimized formulation. pH determination Viscosity measurement (cps) Film formation time (Seconds) Drug content (mg/ml) Cumulative drug permeation after 9 h (%) 5.8 ± 0.01 2.268 ± 0.57 19.54 ± 0.78 8.243 ± 0.43 85.08 ± 0.09 The mechanism of film formation is the evaporation of the solvent base. Solvent drying at room temperature is essential to obtain a film-forming solution that promotes patient compliance. The test revealed the time required for solvent evaporation and production of skin-contacting films. The total drying time of the optimized film-forming solution was 19.54 ± 0.78 s, indicating an ideal value compared to the standard film-forming spray, that is, less than 3 min. 35 The drug content in the optimized film-forming solution was 8.243 ± 0.43 mg\mL. Drug content assessment suggested that the drug was uniformly distributed. Uniformity of the drug content is necessary to ensure the homogeneity of the dispersed drug in the entire formulation. The cumulative drug permeation of the optimized film-forming solution ranged from 21.01 ± 0.06% after 1 hr to 85.08 ± 0.09% after 9 h. Hence, the optimized film-forming curcumin solution containing 5% RLPO, 1% propylene glycol, and 0.5% v/v camphor showed prolonged drug permeation. Comparison of experimental results with predicted responses of optimized formulation Table 7 lists the predicted and experimental values of all response variables and the percentage error. The mean percentage error was 1.04 after comparing the observed and predicted responses. Thus, a low magnitude of error indicated an excellent fit of the model. Table 7. Selected solution and % error between the predicted and the observed values. Factors Responses A B C Film formation time Ex vivo drug permeation Predicted 5% 1% 0.5% 20.50 secs 83.95% Observed 19.54 secs 85.08% Relative % error 0.96 1.13 Evaluation parameters related to the container The volume delivered upon each actuation In this study, assessing the volume delivered per actuation emerged as a pivotal consideration for ensuring the reliability and uniformity of dosing across applications. The experimental findings unveiled a delivered volume of 0.293 ± 0.08 mL for each spray actuation. Spray pattern Evaluation of the spray pattern is an integral aspect in assessing the functionality and performance of the optimized film-forming solution. A visual representation of the spray pattern in Figure 7 empirically confirms the performance of the formulation. This illustration provides tangible insight into the dispersion dynamics of the solution, reaffirming its potential for successful application. Figure 7. Spray pattern of the film-forming solution from the container. Spray angle The spray angle was found to be 72.59° ± 1.43, which was optimal. The actuation amount and spray angle are influenced by the nature of the polymer and its concentration, as well as the viscosity of the formulation. Drug content Determining the amount of curcumin delivered per actuation is a pivotal parameter for assessing the reliability and consistency of drug delivery systems. The findings revealed a consistent delivery of curcumin, with 1.53 ± 0.07 mg delivered per actuation. Ex vivo permeation study An ex vivo animal skin model is the most realistic method for evaluating transdermal formulations and understanding drug permeation through the subcutaneous skin layer. Porcine ear skin shows the most relevant histological structure as human skin, with a subcutaneous thickness of 21–26 μm and hair follicle density of 20/cm 2 . 36 The Figure 8 results indicated that the film-forming spray exhibited the highest drug permeation, showing a significant difference compared to the pure drug solution (p < 0.005), with an exceptional 83.94 ± 0.34% permeation after 9 h. This was accompanied by a flux value of 8.47 ± 0.13 μg/cm 2 /hr and a permeability coefficient of 0.42 ± 0.35 cm 2 /hr. In contrast, owing to its physicochemical properties, the pure drug solution displayed the lowest permeability at 20.23±0.16%. The formulation of curcumin as a film-forming spray significantly elevated drug permeation compared to that of the pure drug solution, demonstrating an enhancement ratio of 14 ( Table 8 ). This enhancement can be attributed to a natural permeation enhancer, 0.5% camphor, which interacts with subcutaneous intracellular lipids, augments the partition coefficient of curcumin. Notably, the permeability of the film-forming spray was slightly superior (enhancement of 1.4) to that of the marketed cream formulation. Figure 8. Ex vivo permeation study. The data represent the mean ± SD. n = 3. The data presented are the mean ± standard deviation (n = 3). Significance was measured by One-way ANOVA. ** indicate the significance between film-forming spray and pure drug (p < 0.005), and * indicate the significance between film-forming spray and marketed formulation (p < 0.05). Table 8. Comparison of permeation data analysis of the pure drug, film-forming spray, and marketed formulation. Parameters Pure drug solution Film forming spray Marketed cream formulation Flux (μg/cm 2 /hr) 0.78 ± 0.09 8.47 ± 0.13 7.61 ± 0.14 Permeability coefficient (cm 2 /hr) 0.03 ± 0.19 0.42 ± 0.35 0.38 ± 0.05 Enhancement ratio - 14.0 12.6 Skin irritation studies Skin irritation is a sign that the skin is exposed to various external stimuli that cause inflammation, without triggering the production of specific antibodies. 37 In the transdermal formulation, skin irritation may be caused by the chemical nature of the API and other excipients. The concentration of the permeability enhancers and the formulation’s contact time duration may be contributory variables. This study was conducted using healthy Wistar rats. Group I was used as the control, Group II was the standard drug group, and Group III was used for the film-forming spray. After visual inspection, the film-forming spray was compatible with rat skin and showed no irritation. The rats were observed after 0 h, 1 d, and 7 d, and readings were recorded. There were no signs of erythema or edema over the entire period of seven days. From the results tabulated in Table 9 and Figure 9 , it can be concluded that the curcumin film-forming spray is irritation-free. Table 9. Skin irritation study. Groups Type Parameter Primary irritation index Erythema Edema Group I Control group - - - Group II Standard Group - - + Group III Film-forming spray - - - Figure 9. Skin irritation study (a) Control 1st day and (b) 7th day, (c) Standard 1st day and (d) 7th day, (e) Film-forming spray 1st day and (f) 7th day. Stability study The formulation was assessed according to the ICH regulatory authority [Q1, R 2 ] accelerated stability conditions and observed changes in the formulation for its film formation capacity in terms of pH, volume delivered, and drug content per actuation using a UV spectrometer. No statistically significant difference (p ≤ 0.05) in the intermediate and the final testing point of the study (three and six months) was observed in the film formation time, pH, actuation volume, and drug content per actuation values compared to the initial formulation. Furthermore, drug content appears to decrease non-significantly from 1.53 ± 0.07 mg/actuation to 1.50 ± 0.27 mg/actuation to 1.49 ± 0.57 mg/actuation to 1.43 ± 0.01 mg/actuation. According to the ICH Q1 R2 guidelines, these minimal changes are acceptable to pass the stability study. The formulated product maintained its quality with respect to its physical and chemical stability over six months at 40 ± 2°C and 75 ± 2% RH. The results of this study are presented in Table 10 . 38 Table 10. Stability evaluation of Film-forming spray formulation. Test parameters Storage conditions Relative humidity Months 0 [Before stability study] 1 3 6 Film-formation time (secs) 40 ± 2°C 75 ± 2% 19.54 ± 0.78 19.41 ± 0.57 20.70 ± 0.22 20.40 ± 0.99 pH 5.8 ± 0.01 5.8 ± 0.41 5.8 ± 0.74 5.8 ± 0.53 Volume delivered upon each actuation (mL) 0.293 ± 0.08 0.190 ± 0.24 0.192 ± 0.27 0.192 ± 0.50 Drug content (mg per actuation) 1.53 ± 0.07 1.50 ± 0.27 1.49 ± 0.57 1.43 ± 0.01 Discussion Computational docking techniques hold immense promise for predicting the potential applicability of a drug by elucidating its interactions with a specific receptor. 39 , 40 The outcomes of the docking investigations shed light on the distinctive properties of different curcumin molecules in their interactions with the target protein. Identifying the optimal binding energy of curcumin and its specific interactions with key residues furthers our understanding of its ligand potential. These findings provide a theoretical foundation for the efficacy of curcumin and pave the way for future experimental validation and potential applications in drug development or therapeutic interventions targeting the nsp10-nsp16 protein complex. The exploration of solvent solubility is inherently tied to supersaturation, a principle pivotal to solvent evaporation from the surface of the skin post-application. The fact that drugs remain soluble in the non-volatile component prevents drug precipitation. The combined mixture of acetone and ethanol increased the vapor pressure compared with the use of a single solvent. 41 The selection of appropriate polymers is a pivotal factor that influences the successful formation of film-forming sprays. 42 The reasonable drying time and non-sticky behavior positioned Eudragit RLPO as the optimal choice for further development and evaluation within the context of this study. A flexible wound film can bend, stretch, and adapt to body movements and changes in the wound area. This is crucial for patient comfort and effective wound healing. When plasticizer molecules are coupled with long polymeric chains, the film functionality is altered. This combination decreases the intermolecular forces and increases the flexibility of the films. 43 The propylene glycol structure has less polarity than PEG 400; therefore, it has a lower ability to bind water. The lower hydrophilicity of propylene glycol leads to greater flexibility of the film. 44 Camphor is a promising natural penetration enhancer because according to a study by Feng Xie et al ., it exhibits a safer and more effective increase in penetration, improving the transdermal permeation of medications with various lipophilicities. 45 The accurate and consistent delivery of a specific volume with each actuation of a spray is a critical parameter that directly influences dosing precision within the application context. The close approximation in volume with minimal variance signifies meticulous design and engineering of the spray mechanism, resulting in a nearly consistent volume of liquid dispensed during each spray. Such a consistent volume is of paramount importance because it plays a dual role in ensuring accurate dosing and forming an effective film over the target area. 46 The spray pattern, denoting the spray’s geometric shape in the cross section, is a defining attribute that characterizes the behavior of the delivered substance upon actuation. 47 The favorable spray pattern, indicative of the optimized solution’s ability to achieve a desirable and uniform cross-sectional shape, further contributes to the formulation’s potential for wound treatment. Spray angles are essential to prevent over-spraying of the film-forming solution onto the skin. It also provides adequate coverage for product application. Gohel et al . stated that the suitable angle for spray determination was less than 85° for easy operation and covering the total surface area. 48 The amount of curcumin delivered with each actuation is of substantial importance, as it directly influences the uniformity of drug distribution and subsequently affects the therapeutic effectiveness of the formulation. The closely aligned quantity, accompanied by minimal variance, signifies meticulous engineering of the delivery mechanism and precise calibration. The enhanced drug permeation observed with the film-forming spray formulation emphasizes its compatibility with the permeation characteristics of curcumin and its potential to enhance patient compliance owing to its convenient administration and transport attributes. This investigation underscores the superiority of the film-forming spray over liquid and semi-solid preparations, establishing its efficacy in terms of permeability. Conclusions The formulation and evaluation of a curcumin film-forming spray for wound healing has shown promising results. Film-forming sprays offer several advantages over traditional topical formulations, including improved absorption, reduced skin irritation, and a consistent dose distribution. A molecular docking study augmented the anti-inflammatory properties of curcumin. The drug was successfully incorporated into a film-forming solution and sprayed with a propellant. The formulated solution exhibited favorable pH and viscosity and demonstrated prolonged permeation of curcumin with high ex vivo drug permeation. Notably, the formulation was found to be a non-irritant, ensuring its suitability for topical applications. This study presents a novel approach to effectively deliver curcumin locally for wound healing, while enhancing patient compliance using a film-forming spray. Further extensive research and clinical studies are warranted to explore the full potential of curcumin-based film formation in wounds and pain management. Authors contributions AS, JC, and AJ conceptualized this study. AS and JC strategized the methods and AS supervised the work. JC and AN conducted the experiments and analyzed the data. AS, MM, PD, AD, and SH interpreted data. PD conceptualized the docking study. MM, AD, AN, and SH designed the figure and performed statistical analysis. All authors aided in drafting the manuscript. All the authors critically reviewed, edited, and approved the final manuscript. Data availability Underlying data Figshare: Underlying data for ‘Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy’, https://www.doi.org/10.6084/m9.figshare.24191067 . 27 Reporting guidelines Figshare: ARRIVE checklist for ‘Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy’, https://www.doi.org/10.6084/m9.figshare.24191067 . 27 Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0) Acknowledgements The authors would like to acknowledge “Vaidyaratnam Ayurveda Research Institute,” Thrissur, Kerala, for assisting with the development of the spray product. References 1. Barchitta M, Maugeri A, Favara G, et al. : Nutrition and Wound Healing: An Overview Focusing on the Beneficial Effects of Curcumin. Int. J. Mol. Sci. 2019 Jan; 20 (5): 1119. PubMed Abstract | Publisher Full Text | Free Full Text 2. Ajazuddin, Saraf S: Applications of novel drug delivery system for herbal formulations. Fitoterapia. 2010 Oct; 81 (7): 680–689. Publisher Full Text 3. Akbik D, Ghadiri M, Chrzanowski W, et al. : Curcumin as a wound healing agent. Life Sci. 2014 Oct 22; 116 (1): 1–7. Publisher Full Text 4. Chopra H, Dey PS, Das D, et al. : Curcumin Nanoparticles as Promising Therapeutic Agents for Drug Targets. Molecules. 2021 Jan; 26 (16): 4998. PubMed Abstract | Publisher Full Text | Free Full Text 5. Mohanty C, Das M, Sahoo SK: Sustained wound healing activity of curcumin loaded oleic acid based polymeric bandage in a rat model. Mol. Pharm. 2012 Oct 1; 9 (10): 2801–2811. PubMed Abstract | Publisher Full Text 6. Cui Z, Yao L, Ye J, et al. : Solubility measurement and thermodynamic modelling of curcumin in twelve pure solvents and three binary solvents at different temperature (T = 278.15–323.15 K). J. Mol. Liq. 2021 Sep 15; 338 : 116795. Publisher Full Text 7. Haq A, Kumar S, Mao Y, et al. : Thymoquinone-Loaded Polymeric Films and Hydrogels for Bacterial Disinfection and Wound Healing. Biomedicine. 2020 Sep 28; 8 (10): 386. Publisher Full Text 8. Kathe K, Kathpalia H: Film forming systems for topical and transdermal drug delivery. Asian J. Pharm. Sci. 2017 Nov 1; 12 (6): 487–497. PubMed Abstract | Publisher Full Text | Free Full Text 9. Wang Y, Hu JS, Lin HQ, et al. : Herbalog: A tool for target-based identification of herbal drug efficacy through molecular docking. Phytomedicine. 2016 Nov 15; 23 (12): 1469–1474. PubMed Abstract | Publisher Full Text 10. Shetty CR, Mendonca V, Shastry CS, et al. : In silico evaluation of pyrazole and triazine containing pyridopyrimidines. Indian Drugs. 2023 Jan 27; 60 (01): 19–32. Publisher Full Text 11. Miyako Y, Khalef N, Matsuzaki K, et al. : Solubility enhancement of hydrophobic compounds by cosolvents: Role of solute hydrophobicity on the solubilization effect. Int. J. Pharm. 2010 Jun 30; 393 (1): 48–54. PubMed Abstract | Publisher Full Text 12. Xie Q, Zheng X, Li L, et al. : Effect of Curcumin Addition on the Properties of Biodegradable Pectin/Chitosan Films. Molecules. 2021 Apr 8; 26 (8): 2152. PubMed Abstract | Publisher Full Text | Free Full Text 13. El Miri N, Aziz F, Aboulkas A, et al. : Effect of plasticizers on physicochemical properties of cellulose nanocrystals filled alginate bionanocomposite films. Adv. Polym. Technol. 2018 Jun 1; 37 : 3171–3185. Publisher Full Text 14. Bhupathyraaj M, Vijaya Rani KR, Sridhar SB, et al. : Effect of Polymers and Permeation Enhancers in the Release of Quetiapine Fumarate Transdermal Patch through the Dialysis Membrane. Polymers (Basel). 2022 May 13; 14 (10): 1984. PubMed Abstract | Publisher Full Text | Free Full Text 15. Abdullah N, Patil A: Application of DoE in polymers screening and optimization of in situ topical ϑilm-forming solution for spray formulation. Int. J. Res. Pharm. Sci. 2020 Dec 21; 11 : 2499–2515. Publisher Full Text 16. Cheng W, Chen J, Liu D, et al. : Impact of ultrasonic treatment on properties of starch film-forming dispersion and the resulting films. Carbohydr. Polym. 2010 Jul 7; 81 (3): 707–711. Publisher Full Text 17. Umar AK, Butarbutar M, Sriwidodo S, et al. : Film-Forming Sprays for Topical Drug Delivery. Drug Des. Devel. Ther. 2020 Dec 31; 14 : 2909–2925. PubMed Abstract | Publisher Full Text | Free Full Text 18. Muzaffar K: Stickiness Problem Associated with Spray Drying of Sugar and Acid Rich Foods: A Mini Review. J. Nutr. Food Sci. 2015 [cited 2023 Aug 24]; s12 . Publisher Full Text 19. Ranade S, Bajaj A, Londhe V, et al. : Fabrication of topical metered dose film forming sprays for pain management. Eur. J. Pharm. Sci. 2017 Mar 30; 100 : 132–141. PubMed Abstract | Publisher Full Text 20. Deattu N, Sunitha PG, Suresh J, et al. : Formulation and Evaluation of Film Forming Gel of Mometasone Furoate. Rochester, NY: 2020 [cited 2023 Aug 20]. 21. Gupta V, Trivedi P: Ex vivo localization and permeation of cisplatin from novel topical formulations through excised pig, goat, and mice skin and in vitro characterization for effective management of skin-cited malignancies. Artif Cells Nanomed Biotechnol. 2015; 43 (6): 373–382. PubMed Abstract | Publisher Full Text 22. Sintov AC, Botner S: Transdermal drug delivery using microemulsion and aqueous systems: Influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems. Int. J. Pharm. 2006 Mar 27; 311 (1): 55–62. PubMed Abstract | Publisher Full Text 23. Response Surface Optimization and In-vitro Evaluation of Sustained Release Topical Insulin Liposomal Spray for Wound Healing. J. App. Pharm. Sci. 2018; 8 (6): 22–29. Publisher Full Text 24. Ignjatović J, Šušteršič T, Bodić A, et al. : Comparative Assessment of in vitro and In Silico Methods for Aerodynamic Characterization of Powders for Inhalation. Pharmaceutics. 2021 Nov; 13 (11): 1831. PubMed Abstract | Publisher Full Text | Free Full Text 25. Smyth H, Hickey AJ, Brace G, et al. : Spray pattern analysis for metered dose inhalers I: Orifice size, particle size, and droplet motion correlations. Drug Dev. Ind. Pharm. 2006 Oct; 32 (9): 1033–1041. PubMed Abstract | Publisher Full Text 26. Wang J, Li Z, Sun F, et al. : Evaluation of dermal irritation and skin sensitization due to vitacoxib. Toxicol. Rep. 2017; 4 : 287–290. PubMed Abstract | Publisher Full Text | Free Full Text 27. Hebbar S, Shetty A: Curcumin film forming topical spray Figshare. [Dataset]. 2023. Publisher Full Text 28. Sritharadol R, Nakpheng T, Wan Sia Heng P, et al. : Development of a topical mupirocin spray for antibacterial and wound-healing applications. Drug Dev. Ind. Pharm. 2017 Oct; 43 (10): 1715–1728. PubMed Abstract | Publisher Full Text 29. Du X, Li Y, Xia YL, et al. : Insights into Protein-Ligand Interactions: Mechanisms, Models, and Methods. Int. J. Mol. Sci. 2016 Jan 26; 17 (2): 144. PubMed Abstract | Publisher Full Text | Free Full Text 30. Jagannathan R, Abraham PM, Poddar P: Temperature-dependent spectroscopic evidences of curcumin in aqueous medium: a mechanistic study of its solubility and stability. J. Phys. Chem. B. 2012 Dec 20; 116 (50): 14533–14540. PubMed Abstract | Publisher Full Text 31. Ghavami R, Biazar E, Taleghani AS, et al. : Design of Curcumin-Loaded Electrospun Polyhydroxybutyrate Mat as a Wound Healing Material. Nano Biomed. Eng. 2020 Mar 31; 12 (1): 14–20. Publisher Full Text 32. Liew KB, Tan YTF, Peh KK: Effect of polymer, plasticizer and filler on orally disintegrating film. Drug Dev. Ind. Pharm. 2014 Jan; 40 (1): 110–119. PubMed Abstract | Publisher Full Text 33. Noebels M, Cross RE, Evans DA, et al. : Characterization of spray-coating methods for conjugated polymer blend thin films. J. Mater. Sci. 2014 Jun 1; 49 (12): 4279–4287. Publisher Full Text 34. Hagen M, Baker M: Skin penetration and tissue permeation after topical administration of diclofenac. Curr. Med. Res. Opin. 2017 Sep; 33 (9): 1623–1634. PubMed Abstract | Publisher Full Text 35. Shababdoust A, Zandi M, Ehsani M, et al. : Controlled curcumin release from nanofibers based on amphiphilic-block segmented polyurethanes. Int. J. Pharm. 2020 Feb 15; 575 : 118947. PubMed Abstract | Publisher Full Text 36. Abd E, Yousef SA, Pastore MN, et al. : Skin models for the testing of transdermal drugs. Clin. Pharmacol. 2016 Oct 19; 8 : 163–176. PubMed Abstract | Publisher Full Text 37. Ahn JH, Eum KH, Lee M: Assessment of the Dermal and Ocular Irritation Potential of Lomefloxacin by Using in vitro Methods. Toxicol. Res. 2010 Mar; 26 (1): 9–14. PubMed Abstract | Publisher Full Text | Free Full Text 38. Jyothi VGSS, Pawar J, Fernandes V, et al. : Film forming topical dermal spray of meloxicam attenuated pain and inflammation in carrageenan-induced paw oedema in Sprague Dawley rats. J. Drug Deliv. Sci. Technol. 2022 Apr 1; 70 : 103195. Publisher Full Text 39. Meng XY, Zhang HX, Mezei M, et al. : Molecular docking: a powerful approach for structure-based drug discovery. Curr. Comput. Aided Drug Des. 2011 Jun; 7 (2): 146–157. PubMed Abstract | Publisher Full Text | Free Full Text 40. Pinzi L, Rastelli G: Molecular Docking: Shifting Paradigms in Drug Discovery. Int. J. Mol. Sci. 2019 Sep 4; 20 (18): 4331. PubMed Abstract | Publisher Full Text | Free Full Text 41. Lee S, Kang T, Lee JY, et al. : Thin-Film Composite Nanofiltration Membranes for Non-Polar Solvents. Membranes (Basel). 2021 Mar 9; 11 (3): 184. PubMed Abstract | Publisher Full Text | Free Full Text 42. Šveikauskaitė I, Briedis V: Effect of Film-Forming Polymers on Release of Naftifine Hydrochloride from Nail Lacquers. Int. J. Polym. Sci. 2017; 2017 : 1–7. Publisher Full Text 43. Zhong Y, Zhuang C, Gu W, et al. : Effect of molecular weight on the properties of chitosan films prepared using electrostatic spraying technique. Carbohydr. Polym. 2019 May 15; 212 : 197–205. PubMed Abstract | Publisher Full Text 44. Hong SH, Cho Y, Kang SW: Formation of Water-Channel by Propylene Glycol into Polymer for Porous Materials. Membranes (Basel). 2021 Nov 16; 11 (11): 881. PubMed Abstract | Publisher Full Text | Free Full Text 45. Xie F, Chai JK, Hu Q, et al. : Transdermal permeation of drugs with differing lipophilicity: Effect of penetration enhancer camphor. Int. J. Pharm. 2016 Jun 30; 507 (1–2): 90–101. PubMed Abstract | Publisher Full Text 46. Naidu H, Kahraman O, Feng H: Novel applications of ultrasonic atomization in the manufacturing of fine chemicals, pharmaceuticals, and medical devices. Ultrason. Sonochem. 2022 May 1; 86 : 105984. PubMed Abstract | Publisher Full Text | Free Full Text 47. Suhag R, Kumar N, Petkoska AT, et al. : Film formation and deposition methods of edible coating on food products: A review. Food Res. Int. 2020 Oct 1; 136 : 109582. PubMed Abstract | Publisher Full Text 48. Gohel MC, Nagori SA: Fabrication of Modified Transport Fluconazole Transdermal Spray Containing Ethyl Cellulose and Eudragit ® RS100 as Film Formers. AAPS PharmSciTech. 2009 May 22; 10 (2): 684–691. PubMed Abstract | Publisher Full Text | Free Full Text Comments on this article Comments (0) Version 1 VERSION 1 PUBLISHED 22 Feb 2024 ADD YOUR COMMENT Comment Author details Author details 1 Department of Pharmaceutics, Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences, Deralakatte, Mangalore, Karnataka, 575018, India 2 Department of Pharma chemistry, Krupanidhi College of Pharmacy, Bangaluru, Karnataka, 560035, India 3 Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India Amitha Shetty Roles: Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Resources, Visualization, Writing – Review & Editing Akhilesh Dubey Roles: Conceptualization, Data Curation, Investigation, Methodology, Project Administration, Resources, Software, Supervision, Validation, Visualization, Writing – Review & Editing Jeshma Chrystle Roles: Conceptualization, Data Curation, Formal Analysis, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Manohar M Roles: Conceptualization, Data Curation, Formal Analysis, Writing – Review & Editing Anish John Roles: Conceptualization, Data Curation, Formal Analysis, Writing – Review & Editing Amitha N Roles: Data Curation, Formal Analysis, Writing – Review & Editing Paramita Das Roles: Data Curation, Software, Supervision, Writing – Review & Editing Srinivas Hebbar Roles: Data Curation, Funding Acquisition, Investigation, Methodology, Supervision, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Competing interests No competing interests were disclosed. Grant information The author(s) declared that no grants were involved in supporting this work. Article Versions (1) version 1 Published: 22 Feb 2024, 13:138 https://doi.org/10.12688/f1000research.142860.1 Copyright © 2024 Shetty A et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Download Export To Sciwheel Bibtex EndNote ProCite Ref. Manager (RIS) Sente metrics Views Downloads F1000Research - - PubMed Central info_outline Data from PMC are received and updated monthly. - - Citations open_in_new 0 open_in_new 0 open_in_new SEE MORE DETAILS CITE how to cite this article Shetty A, Dubey A, Chrystle J et al. Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy [version 1; peer review: 3 approved] . F1000Research 2024, 13 :138 ( https://doi.org/10.12688/f1000research.142860.1 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS track receive updates on this article Track an article to receive email alerts on any updates to this article. TRACK THIS ARTICLE Share Open Peer Review Current Reviewer Status: ? Key to Reviewer Statuses VIEW HIDE Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Version 1 VERSION 1 PUBLISHED 22 Feb 2024 Views 0 Cite How to cite this report: Tiwari R. Reviewer Report For: Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy [version 1; peer review: 3 approved] . F1000Research 2024, 13 :138 ( https://doi.org/10.5256/f1000research.156459.r249577 ) The direct URL for this report is: https://f1000research.com/articles/13-138/v1#referee-response-249577 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 30 May 2024 Ruchi Tiwari , Pranveer Singh Institute of Technology, Kanpur, Uttar Pradesh, India Approved VIEWS 0 https://doi.org/10.5256/f1000research.156459.r249577 Strength The article “Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy” is well within the journal’s scope. The paper introduces a novel method ... Continue reading READ ALL Strength The article “Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy” is well within the journal’s scope. The paper introduces a novel method for delivering curcumin utilizing a film-forming spray, offering a convenient and precise means of administration. The study extensively characterizes the developed formulation, including its pH, viscosity, film formation time, drug content, and permeation properties, providing a thorough understanding of its characteristics. The study demonstrates superior drug permeation compared to traditional cream formulations and pure drug solutions, indicating the effectiveness of the developed film-forming spray in facilitating drug delivery. Opportunity Avoid typographical errors such as and 2 times in the abstract. Inconsistency in the usage of time units; it alternates between “h” and “hr” and “sec” and “s.” Kindly maintain uniformity by choosing one format throughout the manuscript. Include information on the temperature and agitation speed of the shaking water bath during the solubility testing of curcumin in various solvents, as these factors can influence solubility, ensuring the experiment's reproducibility. Specify whether the stickiness evaluation and pH determination were conducted in triplicates, similar to the film formation time assessment, to provide information on the reproducibility and reliability of the experimental findings. Table 5 in the text says optimization results, whereas the skin irritation tests table has been given. Kindly rectify it. Weaknesses: While the study demonstrates promising results in vitro, the absence of in vivo experimentation limits the ability to fully assess the efficacy and safety of the formulated spray in real physiological conditions. However, the authors acknowledge this limitation in the conclusion and suggest further extensive research and clinical studies to address this gap, indicating awareness of the need for further validation. Overall, the topic is relevant. The manuscript is recommended for indexing with the changes to the above-mentioned comments. Is the work clearly and accurately presented and does it cite the current literature? Yes Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Yes If applicable, is the statistical analysis and its interpretation appropriate? I cannot comment. A qualified statistician is required. Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Yes Competing Interests: No competing interests were disclosed. Reviewer Expertise: Pharmaceutical sciences including all aspects of nano drug delivery systems. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Tiwari R. Reviewer Report For: Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy [version 1; peer review: 3 approved] . F1000Research 2024, 13 :138 ( https://doi.org/10.5256/f1000research.156459.r249577 ) The direct URL for this report is: https://f1000research.com/articles/13-138/v1#referee-response-249577 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Views 0 Cite How to cite this report: Mehta T. Reviewer Report For: Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy [version 1; peer review: 3 approved] . F1000Research 2024, 13 :138 ( https://doi.org/10.5256/f1000research.156459.r249576 ) The direct URL for this report is: https://f1000research.com/articles/13-138/v1#referee-response-249576 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 14 May 2024 Tejal Mehta , Department of Pharmaceutics, Institute of Pharmacy, Institute of Pharmacy, Nirma University, Ahmedabad, Gujrat, India Approved VIEWS 0 https://doi.org/10.5256/f1000research.156459.r249576 The work done systematically using experimental design. Results are justified with suitable cases. Following are the suggestions: 1. Include units in Table 2 2. Add the reason to choose particular grade of Eudragit in present study. 3. How ... Continue reading READ ALL The work done systematically using experimental design. Results are justified with suitable cases. Following are the suggestions: 1. Include units in Table 2 2. Add the reason to choose particular grade of Eudragit in present study. 3. How the organic solvent residue is checked in final product? Is the work clearly and accurately presented and does it cite the current literature? Yes Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Yes If applicable, is the statistical analysis and its interpretation appropriate? Yes Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Yes Competing Interests: No competing interests were disclosed. Reviewer Expertise: Novel drug delivery systems and Pharmaceutical Technology I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Mehta T. Reviewer Report For: Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy [version 1; peer review: 3 approved] . F1000Research 2024, 13 :138 ( https://doi.org/10.5256/f1000research.156459.r249576 ) The direct URL for this report is: https://f1000research.com/articles/13-138/v1#referee-response-249576 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Views 0 Cite How to cite this report: Nehete MN. Reviewer Report For: Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy [version 1; peer review: 3 approved] . F1000Research 2024, 13 :138 ( https://doi.org/10.5256/f1000research.156459.r259329 ) The direct URL for this report is: https://f1000research.com/articles/13-138/v1#referee-response-259329 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 18 Apr 2024 Minakshi Nitin Nehete , SNDT Women's University, Maharashtra, India Approved VIEWS 0 https://doi.org/10.5256/f1000research.156459.r259329 The article titled "Fabrication and In vitro Characterization of Curcumin Film-Forming Topical Spray: An Integrated Approach for Enhanced Patient Comfort and Efficacy " presents a well-written account with sufficient detail regarding methods and analysis. It serves as a valuable resource for ... Continue reading READ ALL The article titled "Fabrication and In vitro Characterization of Curcumin Film-Forming Topical Spray: An Integrated Approach for Enhanced Patient Comfort and Efficacy " presents a well-written account with sufficient detail regarding methods and analysis. It serves as a valuable resource for researchers looking to undertake similar research endeavors. The introduction provides comprehensive details regarding the study, including background, rationale, and the selection of curcumin and film-forming spray. However, it fails to specify the types of wounds for which the developed curcumin film-forming spray is intended, such as acute, diabetic, etc. In the methods section, it is noted that each group of laboratory animals only consists of three rats. According to ICH guidelines, a treatment group should ideally contain six animals per group. Additionally, the name of the standard used in the skin irritation study is not mentioned. The article meticulously outlines the formulation and evaluation processes of the curcumin film-forming topical spray. The results section is detailed and informative. In the discussion section, formulation-related aspects are discussed thoroughly. However, the mechanism of action of the curcumin film-forming spray is not addressed in relation to wound healing activity, particularly concerning molecular docking study results. While the article does address some aspects of current literature, it falls short in fully addressing others. Furthermore, in the references section, while most references are from current literature, a few are not up-to-date. Is the work clearly and accurately presented and does it cite the current literature? Partly Is the study design appropriate and is the work technically sound? Partly Are sufficient details of methods and analysis provided to allow replication by others? Yes If applicable, is the statistical analysis and its interpretation appropriate? Yes Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Yes Competing Interests: No competing interests were disclosed. Reviewer Expertise: phytochemical analysis, phytochemistry, pharmacology, molecular docking study I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Nehete MN. Reviewer Report For: Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy [version 1; peer review: 3 approved] . F1000Research 2024, 13 :138 ( https://doi.org/10.5256/f1000research.156459.r259329 ) The direct URL for this report is: https://f1000research.com/articles/13-138/v1#referee-response-259329 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Comments on this article Comments (0) Version 1 VERSION 1 PUBLISHED 22 Feb 2024 ADD YOUR COMMENT Comment keyboard_arrow_left keyboard_arrow_right Open Peer Review Reviewer Status info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Reviewer Reports Invited Reviewers 1 2 3 Version 1 22 Feb 24 read read read Minakshi Nitin Nehete , SNDT Women's University, Maharashtra, India Tejal Mehta , Institute of Pharmacy, Nirma University, Ahmedabad, India Ruchi Tiwari , Pranveer Singh Institute of Technology, Kanpur, India Comments on this article All Comments (0) Add a comment Sign up for content alerts Sign Up You are now signed up to receive this alert Browse by related subjects keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Tiwari R. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 30 May 2024 | for Version 1 Ruchi Tiwari , Pranveer Singh Institute of Technology, Kanpur, Uttar Pradesh, India 0 Views copyright © 2024 Tiwari R. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Strength The article “Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy” is well within the journal’s scope. The paper introduces a novel method for delivering curcumin utilizing a film-forming spray, offering a convenient and precise means of administration. The study extensively characterizes the developed formulation, including its pH, viscosity, film formation time, drug content, and permeation properties, providing a thorough understanding of its characteristics. The study demonstrates superior drug permeation compared to traditional cream formulations and pure drug solutions, indicating the effectiveness of the developed film-forming spray in facilitating drug delivery. Opportunity Avoid typographical errors such as and 2 times in the abstract. Inconsistency in the usage of time units; it alternates between “h” and “hr” and “sec” and “s.” Kindly maintain uniformity by choosing one format throughout the manuscript. Include information on the temperature and agitation speed of the shaking water bath during the solubility testing of curcumin in various solvents, as these factors can influence solubility, ensuring the experiment's reproducibility. Specify whether the stickiness evaluation and pH determination were conducted in triplicates, similar to the film formation time assessment, to provide information on the reproducibility and reliability of the experimental findings. Table 5 in the text says optimization results, whereas the skin irritation tests table has been given. Kindly rectify it. Weaknesses: While the study demonstrates promising results in vitro, the absence of in vivo experimentation limits the ability to fully assess the efficacy and safety of the formulated spray in real physiological conditions. However, the authors acknowledge this limitation in the conclusion and suggest further extensive research and clinical studies to address this gap, indicating awareness of the need for further validation. Overall, the topic is relevant. The manuscript is recommended for indexing with the changes to the above-mentioned comments. Is the work clearly and accurately presented and does it cite the current literature? Yes Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Yes If applicable, is the statistical analysis and its interpretation appropriate? I cannot comment. A qualified statistician is required. Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Yes Competing Interests No competing interests were disclosed. Reviewer Expertise Pharmaceutical sciences including all aspects of nano drug delivery systems. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) Tiwari R. Peer Review Report For: Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy [version 1; peer review: 3 approved] . F1000Research 2024, 13 :138 ( https://doi.org/10.5256/f1000research.156459.r249577) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-138/v1#referee-response-249577 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Mehta T. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 14 May 2024 | for Version 1 Tejal Mehta , Department of Pharmaceutics, Institute of Pharmacy, Institute of Pharmacy, Nirma University, Ahmedabad, Gujrat, India 0 Views copyright © 2024 Mehta T. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions The work done systematically using experimental design. Results are justified with suitable cases. Following are the suggestions: 1. Include units in Table 2 2. Add the reason to choose particular grade of Eudragit in present study. 3. How the organic solvent residue is checked in final product? Is the work clearly and accurately presented and does it cite the current literature? Yes Is the study design appropriate and is the work technically sound? Yes Are sufficient details of methods and analysis provided to allow replication by others? Yes If applicable, is the statistical analysis and its interpretation appropriate? Yes Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Yes Competing Interests No competing interests were disclosed. Reviewer Expertise Novel drug delivery systems and Pharmaceutical Technology I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) Mehta T. Peer Review Report For: Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy [version 1; peer review: 3 approved] . F1000Research 2024, 13 :138 ( https://doi.org/10.5256/f1000research.156459.r249576) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-138/v1#referee-response-249576 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Nehete M. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 18 Apr 2024 | for Version 1 Minakshi Nitin Nehete , SNDT Women's University, Maharashtra, India 0 Views copyright © 2024 Nehete M. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions The article titled "Fabrication and In vitro Characterization of Curcumin Film-Forming Topical Spray: An Integrated Approach for Enhanced Patient Comfort and Efficacy " presents a well-written account with sufficient detail regarding methods and analysis. It serves as a valuable resource for researchers looking to undertake similar research endeavors. The introduction provides comprehensive details regarding the study, including background, rationale, and the selection of curcumin and film-forming spray. However, it fails to specify the types of wounds for which the developed curcumin film-forming spray is intended, such as acute, diabetic, etc. In the methods section, it is noted that each group of laboratory animals only consists of three rats. According to ICH guidelines, a treatment group should ideally contain six animals per group. Additionally, the name of the standard used in the skin irritation study is not mentioned. The article meticulously outlines the formulation and evaluation processes of the curcumin film-forming topical spray. The results section is detailed and informative. In the discussion section, formulation-related aspects are discussed thoroughly. However, the mechanism of action of the curcumin film-forming spray is not addressed in relation to wound healing activity, particularly concerning molecular docking study results. While the article does address some aspects of current literature, it falls short in fully addressing others. Furthermore, in the references section, while most references are from current literature, a few are not up-to-date. Is the work clearly and accurately presented and does it cite the current literature? Partly Is the study design appropriate and is the work technically sound? Partly Are sufficient details of methods and analysis provided to allow replication by others? Yes If applicable, is the statistical analysis and its interpretation appropriate? Yes Are all the source data underlying the results available to ensure full reproducibility? Yes Are the conclusions drawn adequately supported by the results? Yes Competing Interests No competing interests were disclosed. Reviewer Expertise phytochemical analysis, phytochemistry, pharmacology, molecular docking study I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) Nehete MN. Peer Review Report For: Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy [version 1; peer review: 3 approved] . F1000Research 2024, 13 :138 ( https://doi.org/10.5256/f1000research.156459.r259329) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-138/v1#referee-response-259329 Alongside their report, reviewers assign a status to the article: Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions Adjust parameters to alter display View on desktop for interactive features Includes Interactive Elements View on desktop for interactive features Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Stay Updated Sign up for content alerts and receive a weekly or monthly email with all newly published articles Register with F1000Research Already registered? Sign in Not now, thanks close PLEASE NOTE If you are an AUTHOR of this article, please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a “User Comment”. If you are a REVIEWER of this article, please check that you have signed in with the account associated with this article and then go to your account to submit your report, please do not post your review here. If you do not have access to your original account, please contact us . All commenters must hold a formal affiliation as per our Policies . The information that you give us will be displayed next to your comment. User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions . Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available. I accept the User Comment Terms and Conditions Please confirm that you accept the User Comment Terms and Conditions. Affiliation ✕ refresh Please enter your institution. Note: To add your institution or organisation, start typing the name and then select the correct name from the list. Where applicable, the name will appear in both the original language and in English. Do not paste in the name. If the name does not appear in the drop-down list, we will display the information you have entered. ✕ refresh Country/Region * USA UK Canada China France Germany Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Federated States of Micronesia Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo (Serbia and Montenegro) Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Minor Outlying Islands of the United States Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Is South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand The Gambia The Netherlands Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu UK USA Uganda Ukraine United Arab Emirates United States Virgin Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Wallis and Futuna West Bank and Gaza Strip Western Sahara Yemen Zambia Zimbabwe Please select your country/region. You must enter a comment. Competing Interests Please disclose any competing interests that might be construed to influence your judgment of the article's or peer review report's validity or importance. Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Please state your competing interests The comment has been saved. An error has occurred. Please try again. Cancel Post var lTitle = "Fabrication and in vitro characterization...".replace("'", ''); var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/13-138/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by '); var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/13-138/v1&title=" + encodeURIComponent(lTitle); var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/13-138/v1" + "&title=" + encodeURIComponent(lTitle); linkedInUrl += encodeURIComponent('Shetty A et al.'); var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; var addthis_config = { ui_offset_top: offsetTop, services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_custom : [ { name: "LinkedIn", url: linkedInUrl, icon:"/img/icon/at_linkedin.svg" }, { name: "Mendeley", url: "http://www.mendeley.com/import/?url=https://f1000research.com/articles/13-138/v1/mendeley", icon:"/img/icon/at_mendeley.svg" }, { name: "Reddit", url: redditUrl, icon:"/img/icon/at_reddit.svg" }, ] }; var addthis_share = { url: "https://f1000research.com/articles/13-138", templates : { twitter : "Fabrication and in vitro characterization of curcumin film-forming.... Shetty A et al., published by " + "@F1000Research" + ", https://f1000research.com/articles/13-138/v1" } }; if (typeof(addthis) != "undefined"){ addthis.addEventListener('addthis.ready', checkCount); addthis.addEventListener('addthis.menu.share', checkCount); } $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter); $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url); $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url); $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url); $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url); function checkCount(){ setTimeout(function(){ $(".addthis_button_expanded").each(function(){ var count = $(this).text(); if (count !== "" && count != "0") $(this).removeClass("is-hidden"); else $(this).addClass("is-hidden"); }); }, 1000); } close How to cite this report {{reportCitation}} Cancel Copy Citation Details $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');}); $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');}); $.get("/articles/acj/142860/156459") new F1000.Clipboard(); new F1000.ThesaurusTermsDisplay("articles", "article", "156459"); $(document).ready(function() { $( "#frame1" ).on('load', function() { var mydiv = $(this).contents().find("div"); var h = mydiv.height(); console.log(h) }); var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"), titleLivingFigure = tooltipLivingFigure.attr("title"); tooltipLivingFigure.simpletip({ fixed: true, position: ["-115", "30"], baseClass: 'small-tooltip', content:titleLivingFigure + " " }); tooltipLivingFigure.removeAttr("title"); $("body").on("click", ".cite-living-figure", function(e) { e.preventDefault(); var ref = $(this).attr("data-ref"); $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200); }); $("body").on("click", ".close-cite-living-figure", function(e) { e.preventDefault(); $(this).closest(".popup-window-wrapper").fadeOut(200); }); $(document).on("mouseup", function(e) { var metricsContainer = $(".article-metrics-popover-wrapper"); if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) { $(".article-metrics-close-button").click(); } }); var articleId = $('#articleId').val(); if($("#main-article-count-box").attachArticleMetrics) { $("#main-article-count-box").attachArticleMetrics(articleId, { articleMetricsView: true }); } }); var figshareWidget = $(".new_figshare_widget"); if (figshareWidget.length > 0) { window.figshare.load("f1000", function(Widget) { // Select a tag/tags defined in your page. In this tag we will place the widget. _.map(figshareWidget, function(el){ var widget = new Widget({ articleId: $(el).attr("figshare_articleId") //height:300 // this is the height of the viewer part. [Default: 550] }); widget.initialize(); // initialize the widget widget.mount(el); // mount it in a tag that's on your page // this will save the widget on the global scope for later use from // your JS scripts. This line is optional. //window.widget = widget; }); }); } close Error Close Add Reset F1000.MICROSERVICES.AFFILIATION = ''; $(document).ready(function () { $('.js-affiliations-form').each((index, form) => { new AffiliationForm({ formId: form.id, institutionErrorSelector: '.comment-enter-institution', departmentErrorSelector: '.comment-enter-department', placeSelector: '.js-add-comment-place', stateSelector: '.js-add-comment-state', zipCodeSelector: '.js-add-comment-zipcode', countrySelector: '.js-add-comment-country', countryErrorSelector: '.comment-enter-country', }); }); }); $(document).ready(function () { var reportIds = { "259331": 0, "259330": 0, "259329": 6, "259328": 0, "259335": 0, "249575": 0, "259334": 0, "259333": 0, "259332": 0, "249579": 0, "249578": 0, "249577": 2, "249576": 5, "272500": 0, "272501": 0, "272502": 0, "272503": 0, "272498": 0, "272499": 0, "259327": 0, "272504": 0, "272505": 0, "272506": 0, "272507": 0, }; $(".referee-response-container,.js-referee-report").each(function(index, el) { var reportId = $(el).attr("data-reportid"), reportCount = reportIds[reportId] || 0; $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount); }); var uuidInput = $("#article_uuid"), oldUUId = uuidInput.val(), newUUId = "7c442fa2-d032-4c97-ade2-31b4ec57138a"; uuidInput.val(newUUId); $("a[href*='article_uuid=']").each(function(index, el) { var newHref = $(el).attr("href").replace(oldUUId, newUUId); $(el).attr("href", newHref); }); }); An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing. Browse Gateways Collections How it Works Contact For Developers Cookie Notice Privacy Notice RSS Submit Your Research Follow us © 2012-2026 F1000 Research Ltd. ISSN 2046-1402 | Legal | Partner of Research4Life • CrossRef • ORCID • FAIRSharing R.templateTests.simpleTemplate = R.template(' $text $text $text $text $text '); R.templateTests.runTests(); var F1000platform = new F1000.Platform({ name: "f1000research", displayName: "F1000Research", hostName: "f1000research.com", id: "1", editorialEmail: "[email protected]", infoEmail: "[email protected]", usePmcStats: true }); $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');}); // $(function(){R.ui.dropdowns('.dropdown-for-referees');}); $(document).ready(function () { if ($(".cookie-warning").is(":visible")) { $(".sticky").css("margin-bottom", "35px"); $(".devices").addClass("devices-and-cookie-warning"); } $(".cookie-warning .close-button").click(function (e) { $(".devices").removeClass("devices-and-cookie-warning"); $(".sticky").css("margin-bottom", "0"); }); $("#tweeter-feed .tweet-message").each(function (i, message) { var self = $(message); self.html(linkify(self.html())); }); $(".partner").on("mouseenter mouseleave", function() { $(this).find(".gray-scale, .colour").toggleClass("is-hidden"); }); }); Sign In Remember me Forgotten your password? Sign In Cancel Email or password not correct. Please try again Please wait... $(function(){ // Note: All the setup needs to run against a name attribute and *not* the id due the clonish // nature of facebox... $("a[id=googleSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("GOOGLE"); $("form[id=oAuthForm]").submit(); }); $("a[id=facebookSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("FACEBOOK"); $("form[id=oAuthForm]").submit(); }); $("a[id=orcidSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("ORCID"); $("form[id=oAuthForm]").submit(); }); }); If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password. The email address should be the one you originally registered with F1000. Email address not valid, please try again You registered with F1000 via Google, so we cannot reset your password. To sign in, please click here . If you still need help with your Google account password, please click here . You registered with F1000 via Facebook, so we cannot reset your password. To sign in, please click here . If you still need help with your Facebook account password, please click here . Code not correct, please try again Reset password Cancel Email us for further assistance. Server error, please try again. If your email address is registered with us, we will email you instructions to reset your password. If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance. Please wait... Register $(document).ready(function () { signIn.createSignInAsRow($("#sign-in-form-gfb-popup")); $(".target-field").each(function () { var uris = $(this).val().split("/"); if (uris.pop() === "login") { $(this).val(uris.toString().replace(",","/")); } }); });